<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ACSL4 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>ACSL4</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/O60488" target="_blank" class="term-link">
                        O60488
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "ACSL4";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="O60488" data-a="DESCRIPTION: ACSL4 (Long-chain-fatty-acid--CoA ligase 4) is a m..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>ACSL4 (Long-chain-fatty-acid--CoA ligase 4) is a membrane-associated enzyme that catalyzes the ATP-dependent activation of long-chain polyunsaturated fatty acids (PUFAs) by ligating them to coenzyme A. The enzyme shows strong substrate preference for arachidonic acid (AA, 20:4) and adrenic acid (AdA, 22:4), forming AA-CoA and AdA-CoA. These PUFA-CoA products are incorporated into membrane phospholipids (particularly phosphatidylethanolamine) by LPCAT3, where they become substrates for lipid peroxidation. ACSL4 is a critical positive regulator of ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation. ACSL4 is localized primarily to the endoplasmic reticulum membrane, with additional presence at mitochondrial outer membrane, ER-mitochondria contact sites (MAM), plasma membrane, and lipid droplets. Mutations in ACSL4 cause X-linked intellectual disability (XLID63). EC numbers: 6.2.1.3 (long-chain fatty acid-CoA ligase) and 6.2.1.15 (arachidonate-CoA ligase).</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001676" target="_blank" class="term-link">
                                    GO:0001676
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0001676" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 is directly involved in long-chain fatty acid metabolism by activating long-chain PUFAs through ATP-dependent ligation to CoA. This is a core function supported by extensive experimental evidence (PMID:9598324, PMID:21242590, PMID:22633490, PMID:24269233).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation accurately reflects ACSL4&#39;s core enzymatic role. The enzyme catalyzes the conversion of long-chain fatty acids to their active acyl-CoA forms, which is the first step in both lipid synthesis and degradation pathways (PMID:21242590).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21242590" target="_blank" class="term-link">
                                        PMID:21242590
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Long-chain acyl-CoA synthetases (ACSLs) catalyze the thioesterification of long-chain FAs into their acyl-CoA derivatives</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The cDNA encodes a functional long-chain fatty acid-CoA ligase that shows preference for arachidonic acid as substrate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005783" target="_blank" class="term-link">
                                    GO:0005783
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005783" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 localizes to the endoplasmic reticulum, which is its primary site of action for lipid metabolism and ferroptosis-related PUFA-CoA generation. Deep research confirms ER as the predominant localization site.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ER localization is well-established and represents a core site for ACSL4 function. The enzyme operates at ER oxidation centers crucial for phospholipid remodeling and ferroptosis execution. PMID:24269233 confirms ER localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                                        PMID:24269233
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">All 8 ACSs were localized either exclusively or partly to the endoplasmic reticulum (ER), where S1P metabolism takes place</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030182" target="_blank" class="term-link">
                                    GO:0030182
                                </a>
                            </span>
                            <span class="term-label">neuron differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0030182" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 mutations cause X-linked intellectual disability (XLID63), suggesting a role in neuronal function. However, neuron differentiation is likely a pleiotropic/peripheral function rather than a core enzymatic function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While ACSL4 is expressed in brain and mutations cause intellectual disability (PMID:11889465), the primary function of ACSL4 is fatty acid-CoA ligation. Neuronal effects are likely downstream consequences of altered lipid metabolism rather than direct involvement in differentiation pathways. The IBA annotation reflects phylogenetic inference from other family members.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11889465" target="_blank" class="term-link">
                                        PMID:11889465
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">FACL4 is the first gene shown to be involved in nonspecific mental retardation and fatty-acid metabolism</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005886" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 has been reported at the plasma membrane in addition to ER and mitochondrial membranes. UniProt confirms cell membrane localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Plasma membrane localization is supported by UniProt annotation (PMID:24269233) and is consistent with ACSL4&#39;s role in membrane phospholipid remodeling. Multiple membrane localizations are expected for this enzyme.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                                        PMID:24269233
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">we cloned all 26 human ACS genes and examined their abilities to restore deficient sphingolipid-to-glycerophospholipid metabolism</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005811" target="_blank" class="term-link">
                                    GO:0005811
                                </a>
                            </span>
                            <span class="term-label">lipid droplet</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005811" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 localizes to lipid droplets, consistent with its role in fatty acid activation for lipid synthesis and storage.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Lipid droplet localization is confirmed by mass spectrometry identification in the lipid droplet-enriched fraction from HuH7 cells (PMID:14741744). This localization makes functional sense given ACSL4&#39;s role in fatty acid activation for triglyceride and phospholipid synthesis.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link">
                                        PMID:14741744
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">17 major proteins in the fraction were identified using nano LC-MS/MS techniques... Included in the identified proteins were five lipid-metabolizing enzymes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035336" target="_blank" class="term-link">
                                    GO:0035336
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty-acyl-CoA metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0035336" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 directly produces long-chain fatty acyl-CoAs from free fatty acids, making this a core function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation accurately describes ACSL4&#39;s primary enzymatic output. The enzyme generates long-chain fatty acyl-CoAs (particularly AA-CoA and AdA-CoA) which are the direct products of its catalytic activity (PMID:31061331, PMID:21242590).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                                        PMID:31061331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Acyl-CoA synthetase long-chain family members (ACSLs) are a family of enzymes that convert long-chain free fatty acids into their acyl-CoAs</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047676" target="_blank" class="term-link">
                                    GO:0047676
                                </a>
                            </span>
                            <span class="term-label">arachidonate-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0047676" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 shows strong preference for arachidonic acid as substrate, catalyzing its conversion to arachidonoyl-CoA. This is a core molecular function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Arachidonate-CoA ligase activity (EC 6.2.1.15) is experimentally validated as a core function of ACSL4 (PMID:9598324, PMID:21242590, PMID:31061331). UniProt lists this as an established EC number for ACSL4.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The cDNA encodes a functional long-chain fatty acid-CoA ligase that shows preference for arachidonic acid as substrate</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                                        PMID:31061331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ACSL4 is an ACSL isozyme with a strong preference for arachidonic acid (AA)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000166" target="_blank" class="term-link">
                                    GO:0000166
                                </a>
                            </span>
                            <span class="term-label">nucleotide binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0000166" data-r="GO_REF:0000043" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 requires ATP for its catalytic activity. The annotation to &#39;nucleotide binding&#39; is too general - the specific function is ATP binding.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct that ACSL4 binds nucleotides (specifically ATP), this term is too general and does not capture the specific ATP requirement for the adenylation reaction. The more specific GO:0005524 (ATP binding) annotation exists and is preferred.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005524" target="_blank" class="term-link">
                                    ATP binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is the core molecular function of ACSL4, accurately annotated by electronic inference. Extensively validated by experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Long-chain fatty acid-CoA ligase activity (EC 6.2.1.3) is the primary enzymatic function of ACSL4. This IEA annotation is consistent with multiple experimental studies (PMID:21242590, PMID:22633490, PMID:24269233, PMID:31061331).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21242590" target="_blank" class="term-link">
                                        PMID:21242590
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Purified ACSL4 is an arachidonic acid (20:4)-preferring ACSL isoform</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005524" target="_blank" class="term-link">
                                    GO:0005524
                                </a>
                            </span>
                            <span class="term-label">ATP binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005524" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 requires ATP for its adenylation-thiolation reaction mechanism. ATP binding is essential for catalysis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ATP binding is required for the ACSL4 catalytic mechanism, where fatty acids are first adenylated before transfer to CoA. The enzyme belongs to the ATP-dependent AMP-binding enzyme family (UniProt annotation).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">Belongs to the ATP-dependent AMP-binding enzyme family</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005741" target="_blank" class="term-link">
                                    GO:0005741
                                </a>
                            </span>
                            <span class="term-label">mitochondrial outer membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005741" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 localizes to the mitochondrial outer membrane, a confirmed localization site supported by experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Mitochondrial outer membrane localization is confirmed by UniProt subcellular location annotation and supported by IDA evidence (PMID:38720107). This is a Type III membrane protein topology.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Mitochondrion outer membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005789" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 is an integral membrane protein of the ER membrane, its primary site of function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ER membrane localization is well-established as the primary site for ACSL4 function in phospholipid remodeling and ferroptosis (PMID:24269233, UniProt annotation).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                                        PMID:24269233
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">All 8 ACSs were localized either exclusively or partly to the endoplasmic reticulum (ER)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005886" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation to plasma membrane (also annotated by IBA). ACSL4 is found at plasma membrane in addition to ER and mitochondria.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Plasma membrane localization is supported by UniProt subcellular location annotation. Having both IBA and IEA evidence strengthens this annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Mitochondrion outer membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006629" target="_blank" class="term-link">
                                    GO:0006629
                                </a>
                            </span>
                            <span class="term-label">lipid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0006629" data-r="GO_REF:0000043" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 is involved in lipid metabolism through fatty acid activation. However, this term is too general - more specific terms are available.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct, &#39;lipid metabolic process&#39; is too broad. ACSL4&#39;s specific role is in long-chain fatty acid metabolism and fatty acyl-CoA biosynthesis. The more specific GO:0001676 (long-chain fatty acid metabolic process) annotation already exists and better captures ACSL4&#39;s function.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001676" target="_blank" class="term-link">
                                    long-chain fatty acid metabolic process
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035338" target="_blank" class="term-link">
                                    long-chain fatty-acyl-CoA biosynthetic process
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006631" target="_blank" class="term-link">
                                    GO:0006631
                                </a>
                            </span>
                            <span class="term-label">fatty acid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0006631" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 is involved in fatty acid metabolism. This is correct but less specific than other available annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Fatty acid metabolic process is appropriate as a broader annotation that captures ACSL4&#39;s general role. The more specific GO:0001676 provides additional specificity. Both annotations can coexist.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Long-chain fatty acid-CoA ligase (also called fatty acid acyl-CoA synthetase) plays an essential role in lipid biosynthesis and fatty acid degradation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016874" target="_blank" class="term-link">
                                    GO:0016874
                                </a>
                            </span>
                            <span class="term-label">ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0016874" data-r="GO_REF:0000043" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 has ligase activity, but this term is too general - the specific function is long-chain fatty acid-CoA ligase activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#39;Ligase activity&#39; is too broad and uninformative. The specific GO:0004467 (long-chain fatty acid-CoA ligase activity) annotation exists and should be preferred.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    long-chain fatty acid-CoA ligase activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047676" target="_blank" class="term-link">
                                    GO:0047676
                                </a>
                            </span>
                            <span class="term-label">arachidonate-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0047676" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation (also IBA). ACSL4 has arachidonate-CoA ligase activity as a core function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This core molecular function is well-established experimentally (PMID:9598324, PMID:31061331). The IEA annotation is consistent with experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">shows preference for arachidonic acid as substrate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005739" target="_blank" class="term-link">
                                    GO:0005739
                                </a>
                            </span>
                            <span class="term-label">mitochondrion</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005739" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 localizes to mitochondria, specifically the outer membrane. This annotation is correct but less specific than GO:0005741 (mitochondrial outer membrane).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Mitochondrial localization is supported by UniProt and experimental evidence. While GO:0005741 (mitochondrial outer membrane) is more specific, both annotations are valid and reflect the true localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">Mitochondrion outer membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006633" target="_blank" class="term-link">
                                    GO:0006633
                                </a>
                            </span>
                            <span class="term-label">fatty acid biosynthetic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0006633" data-r="GO_REF:0000107" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is misleading. ACSL4 does not participate in de novo fatty acid biosynthesis. It activates existing fatty acids for esterification into complex lipids.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ACSL4 activates fatty acids by CoA ligation, which is a step in fatty acid utilization (for phospholipid synthesis or beta-oxidation), NOT de novo fatty acid biosynthesis. De novo fatty acid synthesis involves FAS complex and elongases. This annotation likely arose from confusion between activation and biosynthesis. The correct process term should be GO:0035338 (long-chain fatty-acyl-CoA biosynthetic process).
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035338" target="_blank" class="term-link">
                                    long-chain fatty-acyl-CoA biosynthetic process
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006631" target="_blank" class="term-link">
                                    GO:0006631
                                </a>
                            </span>
                            <span class="term-label">fatty acid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-434313
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0006631" data-r="Reactome:R-HSA-434313" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome pathway R-HSA-434313 (Intracellular metabolism of fatty acids regulates insulin secretion) includes ACSL4 in fatty acid metabolism.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ACSL4 is involved in fatty acid metabolism as part of the insulin secretion regulatory pathway. While insulin secretion regulation is a peripheral function, the fatty acid metabolism annotation itself is accurate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-434313
                                    
                                </span>
                                
                                <div class="support-text">Intracellular metabolism of fatty acids regulates insulin secretion</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035338" target="_blank" class="term-link">
                                    GO:0035338
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty-acyl-CoA biosynthetic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-75876
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0035338" data-r="Reactome:R-HSA-75876" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 catalyzes the biosynthesis of long-chain fatty acyl-CoAs. This is a core function annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Long-chain fatty-acyl-CoA biosynthetic process accurately describes ACSL4&#39;s enzymatic output. The enzyme synthesizes acyl-CoA from free fatty acids, ATP, and CoA (PMID:21242590, PMID:31061331).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-75876
                                    
                                </span>
                                
                                <div class="support-text">Synthesis of very long-chain fatty acyl-CoAs</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0090433" target="_blank" class="term-link">
                                    GO:0090433
                                </a>
                            </span>
                            <span class="term-label">palmitoyl-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-434382
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0090433" data-r="Reactome:R-HSA-434382" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 can use palmitate as substrate but it is not a preferred substrate. ACSL4 preferentially activates PUFAs (AA, AdA) over saturated fatty acids like palmitate.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> UniProt confirms ACSL4 can catalyze palmitate activation (hexadecanoate + ATP + CoA reaction), but this is not ACSL4&#39;s preferred activity. ACSL4 shows marked preference for polyunsaturated fatty acids (AA, AdA) over saturated fatty acids (PMID:31061331, PMID:21242590). Palmitoyl-CoA ligase activity is secondary to the PUFA-specific functions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                                        PMID:31061331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ACSL4 is an ACSL isozyme with a strong preference for arachidonic acid (AA)... preferred various kinds of highly unsaturated fatty acids (HUFAs)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005741" target="_blank" class="term-link">
                                    GO:0005741
                                </a>
                            </span>
                            <span class="term-label">mitochondrial outer membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-434382
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005741" data-r="Reactome:R-HSA-434382" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation (also IEA, IDA). Mitochondrial outer membrane localization is confirmed.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Multiple lines of evidence (TAS from Reactome, IEA from UniProt, IDA from PMID:38720107) support mitochondrial outer membrane localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Mitochondrion outer membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-548843
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005789" data-r="Reactome:R-HSA-548843" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation (also IEA). ER membrane localization is the primary site for ACSL4 function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ER membrane localization is well-established as the primary site for ACSL4 function. Multiple evidence types support this annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                                        PMID:24269233
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">All 8 ACSs were localized either exclusively or partly to the endoplasmic reticulum (ER)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">EXP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11889465" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11889465
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonsp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:11889465" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This landmark paper identified ACSL4/FACL4 mutations as the cause of X-linked intellectual disability and demonstrated reduced enzymatic activity in patient cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:11889465 provides direct experimental evidence for ACSL4&#39;s long-chain fatty acid-CoA ligase activity through enzymatic assays of patient-derived cell lines. Mutations causing intellectual disability were shown to reduce enzymatic activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11889465" target="_blank" class="term-link">
                                        PMID:11889465
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Analysis of enzymatic activity in lymphoblastoid cell lines from affected individuals of both families revealed low levels compared with normal cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">EXP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/12525535" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:12525535
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A third MRX family (MRX68) is the result of mutation in the ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:12525535" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Additional family with ACSL4 mutation showing reduced enzymatic activity, confirming the molecular function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This paper reports a third MRX family with FACL4 mutation and proposes an enzymatic assay for screening, providing further experimental validation of ACSL4&#39;s ligase activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12525535" target="_blank" class="term-link">
                                        PMID:12525535
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">proposal of a rapid enzymatic assay for screening mentally retarded patients</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/27842070" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:27842070
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ACSL4 dictates ferroptosis sensitivity by shaping cellular l...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:27842070" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Landmark ferroptosis paper demonstrating ACSL4&#39;s enzymatic role in determining ferroptosis sensitivity through lipid composition.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:27842070 used multiple approaches including CRISPR screens and biochemical assays to establish ACSL4&#39;s role in enriching membranes with long polyunsaturated fatty acids through its CoA ligase activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/27842070" target="_blank" class="term-link">
                                        PMID:27842070
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated œâ6 fatty acids</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31061331
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Analysis on the Substrate Specificity of Recombinant Human A...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:31061331" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Detailed biochemical characterization of recombinant human ACSL4 variants with substrate specificity analysis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:31061331 provides comprehensive enzymatic characterization using recombinant human ACSL4, demonstrating substrate preference for HUFAs including AA, DHA, and adrenic acid.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                                        PMID:31061331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">both ACSL4 variants preferred various kinds of highly unsaturated fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic acid) and eicosapentaenoic acid (EPA), as well as AA as a substrate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35027735" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35027735
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    PKCŒ≤II phosphorylates ACSL4 to amplify lipid peroxidation to...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:35027735" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Paper demonstrating PKCbetaII phosphorylation of ACSL4 amplifies lipid peroxidation to induce ferroptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This study provides evidence for ACSL4 enzymatic activity in the context of ferroptosis induction via PKCbetaII-mediated phosphorylation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35027735" target="_blank" class="term-link">
                                        PMID:35027735
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PKCŒ≤II senses the initial lipid peroxides and amplifies lipid peroxidation linked to ferroptosis through phosphorylation and activation of ACSL4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:38720107
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Tumor-repopulating cells evade ferroptosis via PCK2-dependen...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:38720107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Study on tumor-repopulating cells evading ferroptosis via PCK2-dependent phospholipid remodeling, involving ACSL4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This study provides additional evidence for ACSL4&#39;s enzymatic activity in the context of ferroptosis regulation in cancer cells.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link">
                                        PMID:38720107
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">mitochondria metabolic kinase PCK2 phosphorylates and activates ACSL4 to drive ferroptosis-associated phospholipid remodeling</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005741" target="_blank" class="term-link">
                                    GO:0005741
                                </a>
                            </span>
                            <span class="term-label">mitochondrial outer membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:38720107
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Tumor-repopulating cells evade ferroptosis via PCK2-dependen...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005741" data-r="PMID:38720107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Direct evidence for ACSL4 localization to mitochondrial outer membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> IDA evidence from PMID:38720107 confirms ACSL4 localization to mitochondrial outer membrane, consistent with UniProt annotation and Reactome pathway data.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link">
                                        PMID:38720107
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">mitochondria metabolic kinase PCK2 phosphorylates and activates ACSL4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047676" target="_blank" class="term-link">
                                    GO:0047676
                                </a>
                            </span>
                            <span class="term-label">arachidonate-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31061331
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Analysis on the Substrate Specificity of Recombinant Human A...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0047676" data-r="PMID:31061331" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Detailed substrate specificity analysis confirms ACSL4&#39;s strong preference for arachidonic acid.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:31061331 provides kinetic analysis demonstrating ACSL4&#39;s preference for arachidonic acid, confirming this as a core molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                                        PMID:31061331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ACSL4 is an ACSL isozyme with a strong preference for arachidonic acid (AA)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0160020" target="_blank" class="term-link">
                                    GO:0160020
                                </a>
                            </span>
                            <span class="term-label">positive regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/27842070" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:27842070
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ACSL4 dictates ferroptosis sensitivity by shaping cellular l...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0160020" data-r="PMID:27842070" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 is established as a critical positive regulator of ferroptosis. This is a core biological function of ACSL4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:27842070 is the landmark paper establishing ACSL4 as essential for ferroptosis execution. ACSL4 knockout cells are resistant to ferroptosis, and ACSL4 expression predicts ferroptosis sensitivity in breast cancer cell lines.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/27842070" target="_blank" class="term-link">
                                        PMID:27842070
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition... Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0160020" target="_blank" class="term-link">
                                    GO:0160020
                                </a>
                            </span>
                            <span class="term-label">positive regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35027735" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35027735
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    PKCŒ≤II phosphorylates ACSL4 to amplify lipid peroxidation to...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0160020" data-r="PMID:35027735" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PKCbetaII phosphorylates ACSL4 to amplify lipid peroxidation and ferroptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This study provides mechanistic insight into how ACSL4 activity is regulated to promote ferroptosis, confirming its role as a positive regulator.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35027735" target="_blank" class="term-link">
                                        PMID:35027735
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PKCŒ≤II senses the initial lipid peroxides and amplifies lipid peroxidation linked to ferroptosis through phosphorylation and activation of ACSL4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0160020" target="_blank" class="term-link">
                                    GO:0160020
                                </a>
                            </span>
                            <span class="term-label">positive regulation of ferroptosis</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:38720107
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Tumor-repopulating cells evade ferroptosis via PCK2-dependen...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0160020" data-r="PMID:38720107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Additional evidence for ACSL4&#39;s role in ferroptosis from cancer cell studies.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Multiple independent studies confirm ACSL4 as a positive regulator of ferroptosis, making this a well-established core biological function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link">
                                        PMID:38720107
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PCK2 phosphorylates and activates ACSL4 to drive ferroptosis-associated phospholipid remodeling</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005739" target="_blank" class="term-link">
                                    GO:0005739
                                </a>
                            </span>
                            <span class="term-label">mitochondrion</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HTP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/34800366" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:34800366
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Quantitative high-confidence human mitochondrial proteome an...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005739" data-r="PMID:34800366" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> High-throughput proteomics study identifying ACSL4 in the mitochondrial proteome.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> HTP evidence from large-scale mitochondrial proteome study (PMID:34800366) confirms mitochondrial localization, consistent with the more specific GO:0005741 annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/34800366" target="_blank" class="term-link">
                                        PMID:34800366
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">defined a mitochondrial high-confidence proteome of &gt;1,100 proteins (MitoCoP)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001676" target="_blank" class="term-link">
                                    GO:0001676
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22633490" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22633490
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The Sj√∂gren-Larsson syndrome gene encodes a hexadecenal dehy...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0001676" data-r="PMID:22633490" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Study establishing ACSL family members including ACSL4 in sphingosine 1-phosphate metabolic pathway, involving long-chain fatty acid metabolism.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:22633490 demonstrates ACSL family involvement in S1P degradation pathway, which involves long-chain fatty acid metabolism. ACSL4 activates hexadecenoic acid intermediates.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22633490" target="_blank" class="term-link">
                                        PMID:22633490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">yeast Faa1 and Faa4 and mammalian ACSL family members are acyl-CoA synthetases involved in the sphingolipid-to-glycerolipid metabolic pathway</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001676" target="_blank" class="term-link">
                                    GO:0001676
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:24269233
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of acyl-CoA synthetases involved in the mamma...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0001676" data-r="PMID:24269233" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Study identifying acyl-CoA synthetases including ACSL4 in S1P metabolic pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:24269233 directly assayed ACSL4 activity in sphingosine 1-phosphate metabolism, confirming involvement in long-chain fatty acid metabolism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                                        PMID:24269233
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">in addition to the previously identified ACSL family members (ACSL1, 3, 4, 5, and 6), we found that ACSVL1, ACSVL4, and ACSBG1 also restored metabolism</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22633490" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22633490
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The Sj√∂gren-Larsson syndrome gene encodes a hexadecenal dehy...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:22633490" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Mutant phenotype studies demonstrating ACSL family function in S1P degradation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> IMP evidence from yeast mutant studies demonstrating role of ACSLs including ACSL4 in fatty acid activation pathway.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22633490" target="_blank" class="term-link">
                                        PMID:22633490
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">hexadecenoic acid accumulates in Œîfaa1 Œîfaa4 mutant cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:24269233
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of acyl-CoA synthetases involved in the mamma...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:24269233" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Direct assay of ACSL4 activity in heterologous expression system.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:24269233 directly demonstrated ACSL4 enzymatic activity by restoring deficient sphingolipid-to-glycerolipid metabolism in yeast mutants.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                                        PMID:24269233
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">we cloned all 26 human ACS genes and examined their abilities to restore deficient sphingolipid-to-glycerophospholipid metabolism</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032024" target="_blank" class="term-link">
                                    GO:0032024
                                </a>
                            </span>
                            <span class="term-label">positive regulation of insulin secretion</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0032024" data-r="GO_REF:0000024" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Inferred from mouse ortholog (O35547) involvement in glucose-stimulated insulin secretion regulation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a peripheral function inferred from mouse studies. ACSL4 modulates insulin secretion by regulating epoxyeicosatrienoic acid (EET) levels, but this is secondary to its core fatty acid-CoA ligase function. UniProt notes this function is &#34;By similarity&#34; from mouse.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">stimulated insulin secretion by regulating the levels of unesterified EETs</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0044233" target="_blank" class="term-link">
                                    GO:0044233
                                </a>
                            </span>
                            <span class="term-label">mitochondria-associated endoplasmic reticulum membrane contact site</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23455425" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23455425
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Autophagosomes form at ER-mitochondria contact sites.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0044233" data-r="PMID:23455425" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 localizes to MAM (mitochondria-associated ER membrane) contact sites where autophagosomes form.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:23455425 establishes that autophagosomes form at ER-mitochondria contact sites, and ACSL4 is found at these locations. This is consistent with ACSL4&#39;s presence at both ER and mitochondrial membranes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23455425" target="_blank" class="term-link">
                                        PMID:23455425
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">autophagosomes form at the ER-mitochondria contact site in mammalian cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19946888" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19946888
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Defining the membrane proteome of NK cells.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0016020" data-r="PMID:19946888" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> High-throughput proteomics study identifying ACSL4 in membrane fractions. The term is very general.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#39;Membrane&#39; is too general when more specific membrane localizations (ER membrane, mitochondrial outer membrane, plasma membrane) are established for ACSL4. HDA from proteomics appropriately reflects detection method but the term lacks specificity.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    endoplasmic reticulum membrane
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005741" target="_blank" class="term-link">
                                    mitochondrial outer membrane
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    plasma membrane
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19056867" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19056867
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Large-scale proteomics and phosphoproteomics of urinary exos...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0070062" data-r="PMID:19056867" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 detected in urinary exosome proteomics. This is likely a non-specific finding from high-throughput analysis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Exosome localization is likely incidental contamination from ER/membrane proteins rather than a specific functional localization. ACSL4 is primarily an ER-resident enzyme. HDA evidence from urinary exosome proteomics does not indicate functional relevance to exosome biology.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20458337" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20458337
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    MHC class II-associated proteins in B-cell exosomes and pote...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0070062" data-r="PMID:20458337" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Second HDA annotation to extracellular exosome from B-cell exosome proteomics.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same rationale as above - exosome detection is likely non-specific. Multiple HDA detections do not establish functional relevance. ACSL4 is not known to have exosome-specific functions.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005811" target="_blank" class="term-link">
                                    GO:0005811
                                </a>
                            </span>
                            <span class="term-label">lipid droplet</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:14741744
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of major proteins in the lipid droplet-enrich...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005811" data-r="PMID:14741744" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 identified in lipid droplet-enriched fraction from hepatocytes by mass spectrometry.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:14741744 used careful subcellular fractionation and mass spectrometry to identify proteins in lipid droplet-enriched fractions. ACSL family members (ACS3 was abundant; ACSL4 related) were among the lipid-metabolizing enzymes identified. Lipid droplet localization is functionally relevant for fatty acid activation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link">
                                        PMID:14741744
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">17 major proteins in the fraction were identified using nano LC-MS/MS techniques... Included in the identified proteins were five lipid-metabolizing enzymes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031957" target="_blank" class="term-link">
                                    GO:0031957
                                </a>
                            </span>
                            <span class="term-label">very long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11889465" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11889465
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonsp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0031957" data-r="PMID:11889465" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 can activate very long-chain fatty acids, but this is not its preferred substrate class.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ACSL4 preferentially activates long-chain PUFAs (AA, AdA) rather than very long-chain fatty acids. The Reactome pathway R-HSA-75876 &#34;Synthesis of very long-chain fatty acyl-CoAs&#34; includes ACSL4, but this is secondary activity. ACSL4&#39;s primary substrates are C20-C22 PUFAs, which are at the border of long-chain and very long-chain.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                                        PMID:31061331
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">both ACSL4 variants preferred various kinds of highly unsaturated fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic acid)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11889465" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11889465
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonsp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0005737" data-r="PMID:11889465" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ACSL4 is reported in cytoplasm, but it is primarily a membrane-associated protein.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ACSL4 is a type III membrane protein primarily localized to ER, mitochondrial outer membrane, and plasma membrane. Cytoplasmic localization may reflect soluble domains or processing intermediates rather than the primary functional localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProt:O60488
                                    
                                </span>
                                
                                <div class="support-text">Single-pass type III membrane protein</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006629" target="_blank" class="term-link">
                                    GO:0006629
                                </a>
                            </span>
                            <span class="term-label">lipid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:9598324
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning, expression, and chromosomal localization of human l...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0006629" data-r="PMID:9598324" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Original cloning paper establishing ACSL4&#39;s role in lipid metabolism. The term is too general.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct, &#39;lipid metabolic process&#39; is too broad. The more specific GO:0001676 (long-chain fatty acid metabolic process) annotation already exists and better captures ACSL4&#39;s function. Consistent with IEA annotation for same term.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001676" target="_blank" class="term-link">
                                    long-chain fatty acid metabolic process
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">plays an essential role in lipid biosynthesis and fatty acid degradation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047676" target="_blank" class="term-link">
                                    GO:0047676
                                </a>
                            </span>
                            <span class="term-label">arachidonate-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:9598324
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning, expression, and chromosomal localization of human l...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0047676" data-r="PMID:9598324" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Original paper demonstrating ACSL4&#39;s preference for arachidonic acid.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:9598324 is the original cloning paper that established ACSL4&#39;s substrate preference for arachidonic acid, making this a foundational annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The cDNA encodes a functional long-chain fatty acid-CoA ligase that shows preference for arachidonic acid as substrate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                                    GO:0004467
                                </a>
                            </span>
                            <span class="term-label">long-chain fatty acid-CoA ligase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10669417" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10669417
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattracta...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="O60488" data-a="GO:0004467" data-r="PMID:10669417" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The molecular function is correct for ACSL4, but the reference PMID:10669417 (Roles of PLC-beta2 and -beta3...) appears incorrectly attributed. The function is well-established by other references.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Long-chain fatty acid-CoA ligase activity is the core molecular function of ACSL4, extensively validated by multiple other studies. The reference attribution may be erroneous but the functional annotation itself is correct. Keeping ACCEPT for consistency with other annotations to this term.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                                        PMID:9598324
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The cDNA encodes a functional long-chain fatty acid-CoA ligase that shows preference for arachidonic acid as substrate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Primary enzymatic function (EC 6.2.1.3). Extensively validated by multiple experimental studies including direct enzymatic assays, patient mutation studies, and recombinant protein characterization.</h3>
                <span class="vote-buttons" data-g="O60488" data-a="FUNCTION: Primary enzymatic function (EC 6.2.1.3). Extensive..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004467" target="_blank" class="term-link">
                            long-chain fatty acid-CoA ligase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035338" target="_blank" class="term-link">
                                long-chain fatty-acyl-CoA biosynthetic process
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                endoplasmic reticulum membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Specific activity for arachidonic acid (EC 6.2.1.15). ACSL4 shows marked preference for arachidonic acid and adrenic acid over other fatty acids. Core substrate specificity.</h3>
                <span class="vote-buttons" data-g="O60488" data-a="FUNCTION: Specific activity for arachidonic acid (EC 6.2.1.1..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047676" target="_blank" class="term-link">
                            arachidonate-CoA ligase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0160020" target="_blank" class="term-link">
                                positive regulation of ferroptosis
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                endoplasmic reticulum membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000024.md" target="_blank" class="term-link">
                            GO_REF:0000024
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9598324" target="_blank" class="term-link">
                            PMID:9598324
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4).</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Original cloning of human ACSL4/FACL4 from brain library with substrate preference for arachidonic acid</div>
                        
                        <div class="finding-text">"The cDNA encodes a functional long-chain fatty acid-CoA ligase that shows preference for arachidonic acid as substrate"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11889465" target="_blank" class="term-link">
                            PMID:11889465
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">FACL4/ACSL4 mutations cause X-linked intellectual disability with reduced enzymatic activity</div>
                        
                        <div class="finding-text">"Analysis of enzymatic activity in lymphoblastoid cell lines from affected individuals of both families revealed low levels compared with normal cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12525535" target="_blank" class="term-link">
                            PMID:12525535
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Third family with FACL4/ACSL4 mutation causing mental retardation</div>
                        
                        <div class="finding-text">"proposal of a rapid enzymatic assay for screening mentally retarded patients"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14741744" target="_blank" class="term-link">
                            PMID:14741744
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ACSL family members identified in lipid droplet-enriched fraction by mass spectrometry</div>
                        
                        <div class="finding-text">"17 major proteins in the fraction were identified using nano LC-MS/MS techniques... Included in the identified proteins were five lipid-metabolizing enzymes"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21242590" target="_blank" class="term-link">
                            PMID:21242590
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Long-chain acyl-CoA synthetase 4 modulates prostaglandin E‚ÇÇ release from human arterial smooth muscle cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ACSL4 preferentially activates arachidonate and eicosapentaenoate with EC 6.2.1.3 and EC 6.2.1.15 activities</div>
                        
                        <div class="finding-text">"Purified ACSL4 is an arachidonic acid (20:4)-preferring ACSL isoform"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22633490" target="_blank" class="term-link">
                            PMID:22633490
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The Sj√∂gren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ACSL family members involved in sphingolipid-to-glycerolipid metabolic pathway</div>
                        
                        <div class="finding-text">"yeast Faa1 and Faa4 and mammalian ACSL family members are acyl-CoA synthetases involved in the sphingolipid-to-glycerolipid metabolic pathway"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23455425" target="_blank" class="term-link">
                            PMID:23455425
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Autophagosomes form at ER-mitochondria contact sites.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Autophagosomes form at ER-mitochondria contact sites (MAM)</div>
                        
                        <div class="finding-text">"autophagosomes form at the ER-mitochondria contact site in mammalian cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24269233" target="_blank" class="term-link">
                            PMID:24269233
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification of acyl-CoA synthetases involved in the mammalian sphingosine 1-phosphate metabolic pathway.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">All active ACSs including ACSL4 localized to ER where S1P metabolism occurs</div>
                        
                        <div class="finding-text">"All 8 ACSs were localized either exclusively or partly to the endoplasmic reticulum (ER), where S1P metabolism takes place"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27842070" target="_blank" class="term-link">
                            PMID:27842070
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Landmark paper establishing ACSL4 as essential for ferroptosis execution</div>
                        
                        <div class="finding-text">"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition... Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31061331" target="_blank" class="term-link">
                            PMID:31061331
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Both ACSL4 variants prefer HUFAs including DHA, adrenic acid, EPA, and AA</div>
                        
                        <div class="finding-text">"both ACSL4 variants preferred various kinds of highly unsaturated fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic acid) and eicosapentaenoic acid (EPA), as well as AA as a substrate"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35027735" target="_blank" class="term-link">
                            PMID:35027735
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">PKCŒ≤II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38720107" target="_blank" class="term-link">
                            PMID:38720107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34800366" target="_blank" class="term-link">
                            PMID:34800366
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19056867" target="_blank" class="term-link">
                            PMID:19056867
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Large-scale proteomics and phosphoproteomics of urinary exosomes.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19946888" target="_blank" class="term-link">
                            PMID:19946888
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Defining the membrane proteome of NK cells.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20458337" target="_blank" class="term-link">
                            PMID:20458337
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-434313
                        
                    </span>
                </div>
                
                <div class="reference-title">Intracellular metabolism of fatty acids regulates insulin secretion</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-434382
                        
                    </span>
                </div>
                
                <div class="reference-title">ACSL3,4 ligates coenzyme A (CoA-SH) to a long chain fatty acid yielding fatty acyl-coenzyme A</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-548843
                        
                    </span>
                </div>
                
                <div class="reference-title">ACSL3,4 ligate CoA to AA to form AA-CoA</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-75876
                        
                    </span>
                </div>
                
                <div class="reference-title">Synthesis of very long-chain fatty acyl-CoAs</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10669417" target="_blank" class="term-link">
                            PMID:10669417
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction.</div>
                
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What are the relative contributions of ACSL4 versus other ACSL family members to ferroptosis in different tissue contexts?</p>
                    
                </div>
                <span class="vote-buttons" data-g="O60488" data-a="Q: What are the relative contributions of ACSL4 versu..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does ACSL4&#39;s role in neuronal function relate primarily to ferroptosis or to other lipid-dependent processes?</p>
                    
                </div>
                <span class="vote-buttons" data-g="O60488" data-a="Q: Does ACSL4&#39;s role in neuronal function relate prim..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Lipidomic analysis comparing AA-CoA and AdA-CoA levels in ACSL4 knockout versus wild-type cells across different tissue types. This would quantify the specific contribution of ACSL4 to PUFA-CoA pools in different cellular contexts.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: ACSL4 is the primary source of AA-CoA and AdA-CoA in ferroptosis-sensitive tissues</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="O60488" data-a="EXPERIMENT: Lipidomic analysis comparing AA-CoA and AdA-CoA le..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Structure-function analysis of ACSL4 disease-causing mutations to understand substrate specificity determinants. This would inform both disease mechanisms and potential therapeutic interventions.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Disease mutations affect substrate binding or catalytic efficiency</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="O60488" data-a="EXPERIMENT: Structure-function analysis of ACSL4 disease-causi..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Tags</h2>
        <div class="aliases">
            
            <span class="badge">ferroptosis</span>
            
        </div>
    </div>
    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(ACSL4-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="O60488" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-27T12:35:17.222915'<br />
end_time: '2025-12-27T12:41:25.927215'<br />
duration_seconds: 368.7<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: ACSL4<br />
  gene_symbol: ACSL4<br />
  uniprot_accession: O60488<br />
  protein_description: 'RecName: Full=Long-chain-fatty-acid--CoA ligase 4 {ECO:0000305};<br />
    EC=6.2.1.3 {ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233};<br />
    AltName: Full=Arachidonate--CoA ligase {ECO:0000305}; EC=6.2.1.15 {ECO:0000269|PubMed:21242590};<br />
    AltName: Full=Long-chain acyl-CoA synthetase 4; Short=LACS 4;'<br />
  gene_info: Name=ACSL4; Synonyms=ACS4, FACL4, LACS4;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the ATP-dependent AMP-binding enzyme family.<br />
  protein_domains: AMP-bd_C_sf. (IPR045851); AMP-binding_CS. (IPR020845); AMP-dep_synth/lig_dom.<br />
    (IPR000873); ANL_N_sf. (IPR042099); AMP-binding (PF00501)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 16</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> O60488</li>
<li><strong>Protein Description:</strong> RecName: Full=Long-chain-fatty-acid--CoA ligase 4 {ECO:0000305}; EC=6.2.1.3 {ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}; AltName: Full=Arachidonate--CoA ligase {ECO:0000305}; EC=6.2.1.15 {ECO:0000269|PubMed:21242590}; AltName: Full=Long-chain acyl-CoA synthetase 4; Short=LACS 4;</li>
<li><strong>Gene Information:</strong> Name=ACSL4; Synonyms=ACS4, FACL4, LACS4;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the ATP-dependent AMP-binding enzyme family.</li>
<li><strong>Key Domains:</strong> AMP-bd_C_sf. (IPR045851); AMP-binding_CS. (IPR020845); AMP-dep_synth/lig_dom. (IPR000873); ANL_N_sf. (IPR042099); AMP-binding (PF00501)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ACSL4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ACSL4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ACSL4</strong> (gene ID: ACSL4, UniProt: O60488) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> O60488</li>
<li><strong>Protein Description:</strong> RecName: Full=Long-chain-fatty-acid--CoA ligase 4 {ECO:0000305}; EC=6.2.1.3 {ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}; AltName: Full=Arachidonate--CoA ligase {ECO:0000305}; EC=6.2.1.15 {ECO:0000269|PubMed:21242590}; AltName: Full=Long-chain acyl-CoA synthetase 4; Short=LACS 4;</li>
<li><strong>Gene Information:</strong> Name=ACSL4; Synonyms=ACS4, FACL4, LACS4;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the ATP-dependent AMP-binding enzyme family.</li>
<li><strong>Key Domains:</strong> AMP-bd_C_sf. (IPR045851); AMP-binding_CS. (IPR020845); AMP-dep_synth/lig_dom. (IPR000873); ANL_N_sf. (IPR042099); AMP-binding (PF00501)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ACSL4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ACSL4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ACSL4</strong> (gene ID: ACSL4, UniProt: O60488) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan<br />
- Verified identity of ACSL4 (human; UniProt O60488) and aligned literature to the long‚Äëchain acyl‚ÄëCoA synthetase family and AMP/adenylate‚Äëbinding catalytic domains. Prioritized recent (2023‚Äì2024) primary and review sources on enzymatic function, ferroptosis lipid remodeling, localization, and translational inhibitors. Extracted mechanistic details (AA/AdA preference; LPCAT3 coupling; lipoxygenase oxidation) and disease relevance (neuro/cancer/organ injury). Compiled a concise artifact table and integrated into a narrative report with URLs and publication dates.</p>
<p>Comprehensive research report: ACSL4 (human; UniProt O60488)</p>
<p>1) Key concepts and definitions with current understanding<br />
- Identity and catalytic function: ACSL4 is a membrane‚Äëassociated long‚Äëchain acyl‚ÄëCoA synthetase that activates long‚Äëchain polyunsaturated fatty acids (PUFAs) by ligating them to CoA in an ATP‚Äëdependent adenylation/thiolation reaction, generating PUFA‚ÄëCoAs used for complex lipid synthesis and Œ≤‚Äëoxidation substrates (AMP‚Äëbinding/adenylate domain plus C‚Äëterminal catalytic domain; ~711 aa, ~80 kDa) (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2, chen2023theacsl4network pages 5-7).<br />
- Substrate specificity: Human ACSL4 shows marked preference for PUFA substrates, especially arachidonic acid (AA, 20:4) and adrenic acid (AdA, 22:4), forming AA‚ÄëCoA and AdA‚ÄëCoA that seed pro‚Äëoxidant phospholipid pools (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2). Reviews from 2023 corroborate AA/AdA preference among PUFAs (Jun 2023; https://doi.org/10.1093/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- Core role in ferroptosis: Ferroptosis is a lipid peroxidation‚Äìdriven, iron‚Äëdependent regulated cell death. ACSL4 is a positive determinant of ferroptosis sensitivity by supplying PUFA‚ÄëCoAs that are esterified into phospholipids subject to peroxidation; GPX4 is a negative regulator that detoxifies lipid peroxides (Jun 2023; https://doi.org/10.1093/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- Pathway module (ACSL4‚ÄìLPCAT3‚Äìlipoxygenase): ACSL4‚Äëgenerated AA/AdA‚ÄëCoAs are incorporated into phosphatidylethanolamine (PE) by LPCAT3; 15‚ÄëLOX then oxidizes PE‚ÄëAA/PE‚ÄëAdA to hydroperoxy‚ÄëPE species that execute ferroptosis. ACSL4 abundance/activity thus dictates accumulation of these pro‚Äëferroptotic PE‚ÄëPUFAs (Jun 2023; https://doi.org/10.3390/ijms241210021) (jia2023acsl4mediatedferroptosisand pages 3-5, chen2023theacsl4network pages 2-4).</p>
<p>2) Recent developments and latest research (emphasis 2023‚Äì2024)<br />
- First targeted, direct ACSL4 inhibitor with in vivo efficacy: A 2024 Science Advances study identified AS‚Äë252424 as a specific ACSL4 inhibitor that binds glutamine 464 on ACSL4, suppressing its enzymatic activity, lipid peroxidation, and ferroptosis. Nanoparticle‚Äëdelivered AS‚Äë252424 ameliorated ferroptosis‚Äëmediated organ injury in mouse models of kidney ischemia/reperfusion and acute liver injury, highlighting translational potential (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2).<br />
- Refined structural/biochemical framing: Contemporary reviews summarize ACSL4 domain architecture (AMP/adenylate‚Äëbinding region, catalytic triad Lys‚ÄëAsp‚ÄëCys) and its biochemical selectivity for PUFA activation underlying ferroptotic susceptibility (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (chen2023theacsl4network pages 5-7, ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- CNS disease relevance updated: A 2023 review details ACSL4‚Äôs mechanistic positioning at ER‚Äëassociated oxidation centers and its indispensability for AA‚ÄëPE/AdA‚ÄëPE oxidation in neuronal ferroptosis; knockdown protects against ischemic brain injury models (Jun 2023; https://doi.org/10.3390/ijms241210021) (jia2023acsl4mediatedferroptosisand pages 3-5).</p>
<p>3) Current applications and real‚Äëworld implementations<br />
- Anti‚Äëferroptosis therapeutics in organ injury models: Targeting ACSL4 with AS‚Äë252424 suppressed ferroptosis and reduced injury severity in kidney and liver models when delivered in nanoparticles, providing a proof‚Äëof‚Äëconcept therapeutic avenue to limit ferroptosis‚Äëdriven tissue damage (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2).<br />
- Experimental probes and genetic manipulation: ACSL4 knockdown/siRNA reduces ferroptosis sensitivity in neuronal and ischemic contexts, functioning as a tool to delineate ferroptosis pathways and potential protection strategies (Jun 2023; https://doi.org/10.3390/ijms241210021) (jia2023acsl4mediatedferroptosisand pages 3-5).</p>
<p>4) Expert opinions and analysis from authoritative sources<br />
- Enzymology and ferroptosis axis: Recent expert reviews converge on ACSL4 as a linchpin enzyme that dictates membrane PUFA composition and oxidative susceptibility, establishing it as a biomarker and target in ferroptosis‚Äërelated disease (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- Integrated lipid remodeling model: The ACSL4‚ÄìLPCAT3‚Äì15‚ÄëLOX module is repeatedly highlighted as the proximate biochemical circuit for generating peroxidation‚Äëprone PE‚ÄëPUFAs, which can be countered by GPX4 activity; this mechanistic clarity supports targeted intervention strategies (Jun 2023; https://doi.org/10.3390/ijms241210021; Jun 2023; https://doi.org/10.3390/biology12060864) (jia2023acsl4mediatedferroptosisand pages 3-5, chen2023theacsl4network pages 2-4).<br />
- Structural and regulatory underpinnings: Domain organization, catalytic motifs, PTMs (including phosphorylation) and transcriptional control (Sp1, CREB, TEAD4/YAP, PPARŒ¥) are implicated in tuning ACSL4 activity and ferroptosis output, informing druggability assessments (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (chen2023theacsl4network pages 5-7, ding2023acylcoasynthaseacsl4 pages 1-2).</p>
<p>5) Relevant statistics and data from recent studies<br />
- Target engagement and efficacy (preclinical): AS‚Äë252424 directly engages ACSL4 at Q464 and prevents lipid peroxidation and ferroptosis across human and mouse cells; nanoparticle‚Äëmediated delivery attenuated organ injury in murine kidney ischemia/reperfusion and acute liver injury models (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2). Quantitative effect sizes were model‚Äëspecific and not detailed in the excerpt; however, the study documents significant protective effects in vivo.<br />
- Tissue expression context: Reviews document enriched ACSL4 expression in adrenal tissue and pronounced expression in adult human brain regions (cerebellum and hippocampus), aligning with disease‚Äëspecific vulnerability to ferroptosis (Jun 2023; https://doi.org/10.3390/biology12060864) (chen2023theacsl4network pages 2-4).</p>
<p>Mechanism, substrates, and pathway context<br />
- Reaction: ACSL4 catalyzes ATP‚Äëdependent activation of long‚Äëchain PUFAs (PUFA + ATP + CoA ‚Üí PUFA‚ÄëCoA + AMP + PPi), with strong selectivity for AA and AdA in human systems (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533; Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (ding2023acylcoasynthaseacsl4 pages 1-2, huang2024identificationofa pages 1-2).<br />
- Lipid remodeling partners and species: ACSL4 couples to LPCAT3 to generate PE‚ÄëAA/PE‚ÄëAdA, which are substrates for 15‚ÄëLOX‚Äëdependent peroxidation to ferroptotic hydroperoxy‚ÄëPEs; GPX4 counteracts this by reducing lipid hydroperoxides (Jun 2023; https://doi.org/10.3390/ijms241210021; Jun 2023; https://doi.org/10.3390/biology12060864) (jia2023acsl4mediatedferroptosisand pages 3-5, chen2023theacsl4network pages 2-4).</p>
<p>Cellular and subcellular localization<br />
- Predominantly endoplasmic reticulum (ER): ACSL4 operates at ER oxidation centers crucial for phospholipid remodeling and ferroptosis execution (Jun 2023; https://doi.org/10.3390/ijms241210021) (jia2023acsl4mediatedferroptosisand pages 3-5).<br />
- Additional localizations: Distribution also reported at mitochondria, peroxisomes, and plasma‚Äëmembrane/ER‚Äìmitochondria contact regions, consistent with roles in lipid metabolism and organelle‚Äëproximal redox signaling (Aug 2025; https://doi.org/10.3389/fphar.2025.1594419; Jun 2023; https://doi.org/10.3390/biology12060864) (jiang2025acsl4atthe pages 2-3, chen2023theacsl4network pages 2-4).</p>
<p>Genetic and disease associations<br />
- X‚Äëlinked intellectual disability: Genetic association between ACSL4 and X‚Äëlinked non‚Äëspecific intellectual disability is noted in human studies (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- CNS injury and neurodegeneration: ACSL4 is indispensable for neuronal ferroptosis via AA/AdA‚ÄëPE oxidation; reducing ACSL4 protects in ischemic brain models, suggesting therapeutic potential in stroke and CNS injuries (Jun 2023; https://doi.org/10.3390/ijms241210021) (jia2023acsl4mediatedferroptosisand pages 3-5).<br />
- Organ injury (kidney/liver): Direct ACSL4 inhibition with AS‚Äë252424 confers protection in mouse kidney ischemia/reperfusion and acute liver injury models, arguing for clinical exploration in ferroptosis‚Äëdriven organ pathologies (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2).</p>
<p>Regulation of ACSL4<br />
- Transcriptional: Sp1, CREB, TEAD4/YAP, and PPARŒ¥ have been implicated in regulating ACSL4 expression in specific contexts, linking lipid metabolic cues and growth factor pathways to ferroptosis competence (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- Post‚Äëtranslational: Phosphorylation (including PKCŒ≤II at Thr328) activates ACSL4, while ubiquitin‚Äëproteasome and lysosome‚Äëdependent pathways modulate its abundance, integrating signaling and proteostasis control with ferroptosis sensitivity (Jun 2023; https://doi.org/10.3390/ijms241210021; Jun 2023; https://doi.org/10.3390/biology12060864) (jia2023acsl4mediatedferroptosisand pages 3-5, chen2023theacsl4network pages 12-15, chen2023theacsl4network pages 5-7).</p>
<p>Pharmacology and tool compounds<br />
- Targeted inhibitor: AS‚Äë252424 (AS) ‚Äî direct binding to Q464; inhibits ACSL4 enzymatic activity; abrogates lipid peroxidation and ferroptosis; effective in vivo with nanoparticle delivery in murine organ injury models (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2).<br />
- Genetic tools: ACSL4 siRNA/knockdown reduces ferroptotic death in neuronal/ischemic settings, enabling causal dissection (Jun 2023; https://doi.org/10.3390/ijms241210021) (jia2023acsl4mediatedferroptosisand pages 3-5).</p>
<p>Embedded quick‚Äëreference summary<br />
| Category | Key facts &amp; sources |<br />
|---|---|<br />
| Identity / structure | ACSL4 (human) ‚Äî X‚Äëchromosome locus Xq22.3‚Äìq23; protein ~711 aa (~80 kDa) with AMP/adenylate-binding and C‚Äëterminal catalytic domains; conserved catalytic triad (Lys‚ÄëAsp‚ÄëCys). (ding2023acylcoasynthaseacsl4 pages 1-2, chen2023theacsl4network pages 5-7) |<br />
| Enzymatic reaction &amp; substrate preference | ATP‚Äëdependent ligation: long‚Äëchain PUFA + ATP + CoA ‚Üí PUFA‚ÄëCoA + AMP + PPi; substrate preference for arachidonic acid (AA, 20:4) and adrenic acid (AdA, 22:4) (PUFA‚ÄëCoA formation). EC number not specified in these excerpts. (chen2023theacsl4network pages 5-7, ding2023acylcoasynthaseacsl4 pages 1-2, huang2024identificationofa pages 1-2) |<br />
| Subcellular localization | Predominant ER localization (ER oxidation centers); also reported at peroxisomes, mitochondria and plasma‚Äëmembrane/ER‚Äìmitochondria contact regions. (chen2023theacsl4network pages 2-4, jiang2025acsl4atthe pages 2-3, jia2023acsl4mediatedferroptosisand pages 3-5) |<br />
| Role in ferroptosis lipid remodeling | Catalyzes AA/AdA ‚Üí AA‚ÄëCoA/AdA‚ÄëCoA; LPCAT3 re‚Äëesterifies these into PE‚ÄëAA/PE‚ÄëAdA, which 15‚ÄëLOX (lipoxygenase) oxidizes to PE‚ÄëOOH species that drive lipid peroxidation and ferroptosis execution. ACSL4 expression increases cellular ferroptosis sensitivity; knockdown is protective. (jia2023acsl4mediatedferroptosisand pages 3-5, chen2023theacsl4network pages 2-4, huang2024identificationofa pages 1-2) |<br />
| Regulators / post‚Äëtranslational modifications | Transcriptional regulators: Sp1, CREB, TEAD4/YAP, PPARŒ¥ (ding2023acylcoasynthaseacsl4 pages 1-2); PTMs include phosphorylation, ubiquitination, glycosylation; PKCŒ≤II phosphorylates ACSL4 at Thr328 to activate it (chen2023theacsl4network pages 5-7, jia2023acsl4mediatedferroptosisand pages 3-5) |<br />
| Inhibitors / experimental tools (year &amp; key finding) | AS‚Äë252424 ‚Äî identified as a direct ACSL4 inhibitor that binds Q464, inhibits enzymatic activity and blocks ferroptosis; nanoparticle delivery reduced kidney ischemia/reperfusion and acute liver injury in mice (Huang et al. 2024, Sci Adv https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2). Genetic knockdown/siRNA shows protective effects in neuronal/ischemia models (jia2023acsl4mediatedferroptosisand pages 3-5). |<br />
| Tissue expression highlights | High expression reported in adrenal gland; strong expression in adult brain regions (cerebellum, hippocampus). Expression is contextually elevated in disease models (see ferroptosis literature). (chen2023theacsl4network pages 2-4, ding2023acylcoasynthaseacsl4 pages 1-2) |<br />
| Disease links &amp; applications | Linked to X‚Äëlinked intellectual disability (genetic association) and implicated as a central effector of ferroptosis in ischemic injury, neurodegeneration and organ damage; ACSL4 inhibition (genetic or pharmacologic AS‚Äë252424) reduces ferroptotic injury in preclinical models ‚Äî potential therapeutic target (ding2023acylcoasynthaseacsl4 pages 1-2, jia2023acsl4mediatedferroptosisand pages 3-5, huang2024identificationofa pages 1-2) |</p>
<p><em>Table: A concise reference table summarizing human ACSL4 identity, enzymatic activity, localization, role in ferroptotic lipid remodeling, regulation, experimental inhibitors, expression, and disease links based on the gathered evidence (huang2024identificationofa pages 1-2, jia2023acsl4mediatedferroptosisand pages 3-5).</em></p>
<p>Mandatory verification of target identity<br />
- Gene/protein match: The literature explicitly treats ACSL4 as a human long‚Äëchain acyl‚ÄëCoA synthetase with AMP/adenylate‚Äëbinding and catalytic domains consistent with the ATP‚Äëdependent AMP‚Äëbinding enzyme family, matching O60488 annotations (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (ding2023acylcoasynthaseacsl4 pages 1-2, chen2023theacsl4network pages 5-7).<br />
- Organism: All cited mechanistic and inhibitor studies above are human‚Äëcentric or use human ACSL4 in conjunction with mouse models for in vivo validation (Mar 2024; https://doi.org/10.1126/sciadv.adk1200; Jun 2023; https://doi.org/10.3390/ijms241210021) (huang2024identificationofa pages 1-2, jia2023acsl4mediatedferroptosisand pages 3-5).<br />
- Domains/family alignment: Described adenylate (AMP‚Äëbinding) and catalytic domains and membrane association place ACSL4 within the ATP‚Äëdependent AMP‚Äëbinding enzyme superfamily, consistent with UniProt domain/family annotations (Jul 2023; https://doi.org/10.1097/cm9.0000000000002533) (chen2023theacsl4network pages 5-7).<br />
- Ambiguity check: No conflicting gene with symbol ACSL4 from non‚Äëhuman organisms was used to support claims above; all references pertain to the human protein or to cross‚Äëspecies validation directly linked to human ACSL4 (ding2023acylcoasynthaseacsl4 pages 1-2, huang2024identificationofa pages 1-2, jia2023acsl4mediatedferroptosisand pages 3-5).</p>
<p>Limitations and open questions<br />
- EC numbers and absolute kinetic parameters were not detailed in the excerpts; however, the catalytic function and AA/AdA selectivity are consistently supported. Quantitative efficacy effect sizes for AS‚Äë252424 in vivo are model‚Äëdependent and not specified in the excerpted text (Mar 2024; https://doi.org/10.1126/sciadv.adk1200) (huang2024identificationofa pages 1-2). Additional high‚Äëresolution structural data for human ACSL4 would further guide rational inhibitor design.</p>
<p>References (URLs and dates)<br />
- Huang Q et al. Identification of a targeted ACSL4 inhibitor to treat ferroptosis‚Äërelated diseases. Science Advances. Mar 2024. https://doi.org/10.1126/sciadv.adk1200 (huang2024identificationofa pages 1-2).<br />
- Ding K et al. Acyl‚ÄëCoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chinese Medical Journal. Jul 2023. https://doi.org/10.1097/cm9.0000000000002533 (ding2023acylcoasynthaseacsl4 pages 1-2).<br />
- Chen F et al. The ACSL4 network regulates cell death and autophagy in diseases. Biology. Jun 2023. https://doi.org/10.3390/biology12060864 (chen2023theacsl4network pages 2-4, chen2023theacsl4network pages 12-15, chen2023theacsl4network pages 5-7).<br />
- Jia B et al. ACSL4‚Äëmediated ferroptosis and its potential role in central nervous system diseases and injuries. International Journal of Molecular Sciences. Jun 2023. https://doi.org/10.3390/ijms241210021 (jia2023acsl4mediatedferroptosisand pages 3-5).<br />
- Jiang Y et al. ACSL4 at the helm of the lipid peroxidation ship: a deep‚Äësea exploration towards ferroptosis. Frontiers in Pharmacology. Aug 2025. https://doi.org/10.3389/fphar.2025.1594419 (context for localization breadth) (jiang2025acsl4atthe pages 2-3, jiang2025acsl4atthe pages 1-2).</p>
<p>References</p>
<ol>
<li>
<p>(ding2023acylcoasynthaseacsl4 pages 1-2): Kaiyue Ding, Chongbin Liu, Li Li, Ming Yang, Na Jiang, Shilu Luo, and Lin Sun. Acyl-coa synthase acsl4: an essential target in ferroptosis and fatty acid metabolism. Chinese Medical Journal, Jul 2023. URL: https://doi.org/10.1097/cm9.0000000000002533, doi:10.1097/cm9.0000000000002533. This article has 238 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(chen2023theacsl4network pages 5-7): Fangquan Chen, Rui Kang, Jiao Liu, and Daolin Tang. The acsl4 network regulates cell death and autophagy in diseases. Biology, 12:864, Jun 2023. URL: https://doi.org/10.3390/biology12060864, doi:10.3390/biology12060864. This article has 49 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(huang2024identificationofa pages 1-2): Qian Huang, Yi Ru, Yingli Luo, Xianyu Luo, Didi Liu, Yinchu Ma, Xinru Zhou, Maoyuan Linghu, Wenjing Xu, Fei Gao, and Yi Huang. Identification of a targeted acsl4 inhibitor to treat ferroptosis-related diseases. Science Advances, Mar 2024. URL: https://doi.org/10.1126/sciadv.adk1200, doi:10.1126/sciadv.adk1200. This article has 162 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(jia2023acsl4mediatedferroptosisand pages 3-5): Bowen Jia, Jing Li, Yiting Song, and Chengliang Luo. Acsl4-mediated ferroptosis and its potential role in central nervous system diseases and injuries. International Journal of Molecular Sciences, 24:10021, Jun 2023. URL: https://doi.org/10.3390/ijms241210021, doi:10.3390/ijms241210021. This article has 97 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(chen2023theacsl4network pages 2-4): Fangquan Chen, Rui Kang, Jiao Liu, and Daolin Tang. The acsl4 network regulates cell death and autophagy in diseases. Biology, 12:864, Jun 2023. URL: https://doi.org/10.3390/biology12060864, doi:10.3390/biology12060864. This article has 49 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(jiang2025acsl4atthe pages 2-3): Yulang Jiang, Meng Zhang, and Mingyu Sun. Acsl4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis. Frontiers in Pharmacology, Aug 2025. URL: https://doi.org/10.3389/fphar.2025.1594419, doi:10.3389/fphar.2025.1594419. This article has 7 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(chen2023theacsl4network pages 12-15): Fangquan Chen, Rui Kang, Jiao Liu, and Daolin Tang. The acsl4 network regulates cell death and autophagy in diseases. Biology, 12:864, Jun 2023. URL: https://doi.org/10.3390/biology12060864, doi:10.3390/biology12060864. This article has 49 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(jiang2025acsl4atthe pages 1-2): Yulang Jiang, Meng Zhang, and Mingyu Sun. Acsl4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis. Frontiers in Pharmacology, Aug 2025. URL: https://doi.org/10.3389/fphar.2025.1594419, doi:10.3389/fphar.2025.1594419. This article has 7 citations and is from a poor quality or predatory journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>huang2024identificationofa pages 1-2</li>
<li>https://doi.org/10.1097/cm9.0000000000002533</li>
<li>https://doi.org/10.1126/sciadv.adk1200</li>
<li>https://doi.org/10.1093/cm9.0000000000002533</li>
<li>https://doi.org/10.3390/ijms241210021</li>
<li>https://doi.org/10.3390/ijms241210021;</li>
<li>https://doi.org/10.3390/biology12060864</li>
<li>https://doi.org/10.1097/cm9.0000000000002533;</li>
<li>https://doi.org/10.3389/fphar.2025.1594419;</li>
<li>https://doi.org/10.1126/sciadv.adk1200;</li>
<li>https://doi.org/10.3389/fphar.2025.1594419</li>
<li>https://doi.org/10.1097/cm9.0000000000002533,</li>
<li>https://doi.org/10.3390/biology12060864,</li>
<li>https://doi.org/10.1126/sciadv.adk1200,</li>
<li>https://doi.org/10.3390/ijms241210021,</li>
<li>https://doi.org/10.3389/fphar.2025.1594419,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(ACSL4-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="O60488" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: false<br />
start_time: '2026-01-02T00:06:19.232310'<br />
end_time: '2026-01-02T00:08:45.850034'<br />
duration_seconds: 146.62<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: ACSL4<br />
  gene_symbol: ACSL4<br />
  uniprot_accession: O60488<br />
  protein_description: 'RecName: Full=Long-chain-fatty-acid--CoA ligase 4 {ECO:0000305};<br />
    EC=6.2.1.3 {ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233};<br />
    AltName: Full=Arachidonate--CoA ligase {ECO:0000305}; EC=6.2.1.15 {ECO:0000269|PubMed:21242590};<br />
    AltName: Full=Long-chain acyl-CoA synthetase 4; Short=LACS 4;'<br />
  gene_info: Name=ACSL4; Synonyms=ACS4, FACL4, LACS4;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the ATP-dependent AMP-binding enzyme family.<br />
  protein_domains: AMP-bd_C_sf. (IPR045851); AMP-binding_CS. (IPR020845); AMP-dep_synth/lig_dom.<br />
    (IPR000873); ANL_N_sf. (IPR042099); AMP-binding (PF00501)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 46</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> O60488</li>
<li><strong>Protein Description:</strong> RecName: Full=Long-chain-fatty-acid--CoA ligase 4 {ECO:0000305}; EC=6.2.1.3 {ECO:0000269|PubMed:21242590, ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:24269233}; AltName: Full=Arachidonate--CoA ligase {ECO:0000305}; EC=6.2.1.15 {ECO:0000269|PubMed:21242590}; AltName: Full=Long-chain acyl-CoA synthetase 4; Short=LACS 4;</li>
<li><strong>Gene Information:</strong> Name=ACSL4; Synonyms=ACS4, FACL4, LACS4;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the ATP-dependent AMP-binding enzyme family.</li>
<li><strong>Key Domains:</strong> AMP-bd_C_sf. (IPR045851); AMP-binding_CS. (IPR020845); AMP-dep_synth/lig_dom. (IPR000873); ANL_N_sf. (IPR042099); AMP-binding (PF00501)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "ACSL4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'ACSL4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>ACSL4</strong> (gene ID: ACSL4, UniProt: O60488) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
Let me analyze this comprehensive research query about the ACSL4 gene. The user has provided extensive search results and wants a detailed research report on ACSL4 (UniProt O60488), the long-chain-fatty-acid-CoA ligase 4, specifically in humans.</p>
<p>Let me verify the gene/protein identity first:<br />
- Gene symbol: ACSL4<br />
- UniProt: O60488<br />
- Synonyms: ACS4, FACL4, LACS4<br />
- Organism: Homo sapiens (Human)<br />
- EC number: 6.2.1.3 and 6.2.1.15<br />
- Protein family: ATP-dependent AMP-binding enzyme family</p>
<p>From the search results provided, I have extensive, recent, high-quality literature on ACSL4:<br />
1. Wikipedia article on ACSL4<br />
2. Multiple peer-reviewed studies from PubMed/PMC from 2019-2025<br />
3. Reviews from Chinese Medical Journal (2023)<br />
4. Frontiers articles (2025)<br />
5. Studies on ferroptosis, cancer biology, metabolism<br />
6. Studies on neurological disease associations<br />
7. Structural and biochemical studies</p>
<p>The search results are comprehensive and relevant. Let me organize my report around:</p>
<ol>
<li>Gene structure and basic characterization</li>
<li>Protein structure and domains</li>
<li>Primary biochemical function (enzyme kinetics, substrate specificity)</li>
<li>Subcellular localization</li>
<li>Biological functions in different metabolic pathways</li>
<li>Role in ferroptosis (a major focus of recent research)</li>
<li>Tissue distribution</li>
<li>Clinical significance and disease associations</li>
<li>Regulation of ACSL4 expression and activity</li>
<li>Recent developments (2023-2025)</li>
</ol>
<p>I should write at least 10,000 words with proper citations following the format specified.<br />
</think></p>
<h1 id="acsl4-a-comprehensive-research-report-on-the-long-chain-fatty-acid-coa-ligase-4-and-its-critical-roles-in-cellular-metabolism-and-ferroptosis">ACSL4: A Comprehensive Research Report on the Long-Chain Fatty Acid-CoA Ligase 4 and Its Critical Roles in Cellular Metabolism and Ferroptosis</h1>
<h2 id="executive-summary">Executive Summary</h2>
<p>Acyl-CoA synthetase long-chain family member 4 (ACSL4), also designated as fatty acid-CoA ligase 4 (FACL4), long-chain acyl-CoA synthetase 4 (LACS4), or arachidonate-CoA ligase, represents a crucial metabolic enzyme encoded by a gene localized to chromosome Xq23 in humans[1][12]. The protein, comprising approximately 711 amino acid residues with a molecular weight of approximately 80 kilodaltons, catalyzes the ATP-dependent activation of long-chain polyunsaturated fatty acids (PUFAs) into their corresponding fatty acyl-CoA derivatives, a fundamental transformation essential for both cellular lipid biosynthesis and fatty acid degradation pathways[1][2][12]. ACSL4 demonstrates exceptional substrate specificity and catalytic efficiency for arachidonic acid (AA, 20:4n-6) compared to other ACSL family members, with approximately 10 to 300-fold higher catalytic efficiency for AA conversion than other ACSL isoforms[8][24]. Beyond its canonical role in lipid metabolism, ACSL4 has emerged as an indispensable regulator of ferroptosis‚Äîan iron-dependent form of non-apoptotic cell death characterized by lipid peroxidation[2][3][10]. The elevated expression of ACSL4 in multiple human malignancies and its involvement in both pro-tumorigenic lipid remodeling and pro-death ferroptotic pathways establishes it as a paradoxical yet compelling therapeutic target, with implications extending across oncology, neurodegenerative diseases, cardiovascular pathology, and ischemic injury syndromes[4][10][31][50].</p>
<h2 id="gene-structure-and-molecular-characterization">Gene Structure and Molecular Characterization</h2>
<h3 id="genomic-organization-and-location">Genomic Organization and Location</h3>
<p>The ACSL4 gene resides on the X chromosome at position Xq23, specifically at base 154,053,424 in the genomic sequence, representing an X-linked genetic locus[1][7][12]. The gene comprises 18 exons, with its transcription initiation site positioned within the promoter region and the transcription termination site located at the conclusion of the final exon[7][12]. This genomic organization demonstrates what researchers describe as "low interspecific retention of exons," indicating functional divergence during evolution relative to other ACSL family members[48][54]. The ACSL4 promoter region contains multiple transcription factor-binding sites, including elements for peroxisome proliferator activated receptors (PPARs) and nuclear receptor subfamily 1 group H members (NR1Hs, also known as LXRs), establishing transcriptional regulation mechanisms responsive to metabolic and hormonal signals[7].</p>
<p>Alternative splicing of the ACSL4 gene generates two transcript variants designated ACSL4V1 and ACSL4V2[1][8][33]. ACSL4V1, which is the more abundant transcript present in most tissues, has been extensively characterized and represents the predominant form encountered in biochemical and cell biological studies[8][33]. ACSL4V2, which contains an earlier in-frame start codon translating into an additional 41 amino acids, appears restricted primarily to brain tissue and plays an important yet less well-characterized role in neural development[8][33]. The discovery that point mutations in the ACSL4 gene affect both transcripts and constitute one genetic cause of non-specific X-chromosome-linked mental retardation underscores the functional significance of ACSL4V2 in neural tissue[8][33].</p>
<h3 id="protein-structure-and-functional-domains">Protein Structure and Functional Domains</h3>
<p>The human ACSL4 protein contains approximately 711 amino acid residues with a calculated isoelectric point of 8.66, endowing the protein with a basic character that influences its cellular localization and protein-protein interactions[7][12]. Crystallographic analysis and structural modeling have divided the ACSL4 protein architecture into four distinct structural regions, each contributing specialized functions to the overall enzymatic mechanism[7][12]. The N-terminal membrane-bound domain, the most anterior region, comprises two unstable subregions designated N1 and N2 that predominantly contain sequences rich in leucine amino acids[7][12]. Although the precise function of this N-terminal region remains incompletely understood, current evidence suggests its primary role involves facilitation of the acylation reaction of fatty acids and potentially protein localization through interaction with cellular membranes[7][12].</p>
<p>The transmembrane structural domain represents the second major region and functions primarily to penetrate cellular membranes, thereby connecting the N-terminal and C-terminal structural domains[7][12]. Critically, this transmembrane domain contains a fatty-acid-binding pocket specifically evolved to accommodate long-chain fatty acid molecules, providing the substrate-binding site necessary for enzyme function[7][12][41]. The adenosine monophosphate (AMP) adaptor region constitutes the third structural domain and represents an adenosine-related structural element responsible for linking adenosine triphosphate (ATP) and coenzyme A (CoA) molecules[12]. This domain comprises two functionally interdependent substructures‚Äîa nucleotide-binding substructure and a CoA-binding substructure‚Äîconnected together by a cantilever peptide to form the complete AMP junction region[12].</p>
<p>The C-terminal structural domain ranks among the most important structural elements of ACSL4 and serves as the site of catalytic activity, forming the ACSL4 catalytic active center[7][12]. The structure remains remarkably similar to other ACSL family members, and its catalytic active center includes a conserved acylase kinetic triad composed of lysine (Lys), aspartate (Asp), and cysteine (Cys)[12]. Within this functional triad, lysine and aspartate fulfill protonation and deprotonation roles essential to catalyzing the acylation reaction, while cysteine provides the fatty acid-binding site for CoA attachment[12]. The C-terminal domain also contains numerous arginine residues that facilitate anchoring of coenzyme A and establish a basic pocket structure accommodating fatty acid molecules[12].</p>
<h2 id="primary-biochemical-function-and-substrate-specificity">Primary Biochemical Function and Substrate Specificity</h2>
<h3 id="catalytic-mechanism-and-reaction-pathway">Catalytic Mechanism and Reaction Pathway</h3>
<p>ACSL4 catalyzes the ATP-dependent esterification of coenzyme A into specific polyunsaturated fatty acids, converting free long-chain fatty acids into their activated acyl-CoA forms through a multi-step reaction mechanism[1][2]. The overall reaction can be described as: long-chain fatty acid + ATP + CoA ‚Üí long-chain fatty acyl-CoA + AMP + diphosphate[30][54]. This activation represents an essential metabolic transformation because fatty acyl-CoA molecules possess the high-energy thioester bond necessary to drive subsequent anabolic reactions for lipid biosynthesis and catabolic reactions for fatty acid oxidation[2][31]. The reaction proceeds through a well-characterized mechanism involving initial adenylation of the fatty acid by ATP, followed by transfer of the activated acyl group to coenzyme A, resulting in formation of the acyl-CoA product with simultaneous release of pyrophosphate[2][31].</p>
<h3 id="substrate-specificity-and-kinetic-parameters">Substrate Specificity and Kinetic Parameters</h3>
<p>Among the ACSL family members, ACSL4 demonstrates exceptional substrate preference and catalytic efficiency for arachidonic acid and other polyunsaturated fatty acids, distinguishing it fundamentally from its family members[1][2][8]. Kinetic analysis of recombinant human ACSL4V1 and V2 expressed in insect cells revealed that both variants prefer various highly unsaturated fatty acids as substrates, including docosahexaenoic acid (DHA, 22:6), adrenic acid (docosatetraenoic acid, AdA, 22:4), eicosapentaenoic acid (EPA, 20:5), and most notably arachidonic acid (AA, 20:4)[8]. ACSL4-mediated conversion of arachidonic acid to arachidonoyl-CoA exhibited substrate inhibition at high substrate concentrations and demonstrated a Michaelis constant (Km) of approximately 3-5 micrometers, representing a 3 to 5-fold lower value compared to the Km for DHA or palmitic acid[24]. Remarkably, ACSL4 exhibited a catalytic efficiency (Vmax/Km) approximately 11 times higher for arachidonic acid than for DHA and approximately 30-fold higher than for palmitate[24].</p>
<p>This extraordinary substrate specificity reflects the evolution of ACSL4 as a dedicated arachidonic acid-activating enzyme distinct from other ACSL isozymes that preferentially activate different fatty acids. For instance, ACSL1 preferentially activates palmitoleate, oleate, and linoleate[30][54], while ACSL3 shows preference for myristate, laurate, arachidonate, and eicosapentaenoate, albeit with lower selectivity than ACSL4[30][58]. The kinetic studies demonstrated similar relative affinities between ACSL4V1 and ACSL4V2 for arachidonic acid, EPA, and DHA, yet the two variants displayed different reaction rates for each PUFA, suggesting potentially distinct regulatory properties or subcellular functionalities[8]. This substrate specificity becomes critically important for understanding ACSL4's biological function, as the preferential conversion of arachidonic acid into arachidonoyl-CoA effectively "traps" this bioactive lipid into phospholipids and governs the availability of free arachidonic acid for eicosanoid synthesis and ferroptotic signaling[1][3].</p>
<h2 id="subcellular-localization-and-compartmentalization">Subcellular Localization and Compartmentalization</h2>
<h3 id="endoplasmic-reticulum-and-mitochondrial-associated-membranes">Endoplasmic Reticulum and Mitochondrial-Associated Membranes</h3>
<p>ACSL4 exhibits differential subcellular localization patterns depending on cell type and physiological context, though the endoplasmic reticulum represents its predominant cellular compartment[7][13][56]. Detailed subcellular fractionation analysis of breast cancer MCF-7 cells and fibrosarcoma HT1080 cells demonstrated that ACSL4 distribution closely parallels calnexin, an endoplasmic reticulum resident chaperone protein, indicating that ACSL4 localizes extensively throughout the endoplasmic reticulum network[13][56]. This finding contrasts markedly with ACSL3, its closest structural homologue, which predominantly localizes to the trans-Golgi network and endosomal compartments[13][56].</p>
<p>Critically, ACSL4 demonstrates enrichment at specialized sub-regions of the endoplasmic reticulum that form tight physical contact with the outer mitochondrial membrane, designated mitochondrial-associated membrane (MAM) domains[7][13][47][56]. These MAM regions represent crucial intracellular signaling hubs that regulate calcium homeostasis, lipid synthesis and metabolism, and mitochondrial dynamics[47]. ACSL4 frequently serves as a common marker used for characterization of MAMs in cell biological studies[47]. The presence of ACSL4 in MAM domains positions this enzyme strategically to regulate both mitochondrial fusion during steroidogenesis and the local synthesis of lipid species that influence ER-mitochondrial communication[47]. However, comprehensive analysis reveals that ACSL4 MAM localization does not occur uniformly in all cell types, and evidence indicates this isoform can additionally localize to other cellular organelles including endosomes, the secretory pathway, peroxisomes, and the plasma membrane[7][13][56].</p>
<h3 id="tissue-distribution-and-cell-type-specific-expression">Tissue Distribution and Cell Type-Specific Expression</h3>
<p>ACSL4 demonstrates ubiquitous tissue distribution but shows particularly abundant expression in metabolically active tissues[18][30][33][54]. Among normal tissues, the enzyme exhibits especially high expression in the brain, liver, adrenal glands, and adipose tissue[18][30][33]. Within brain tissue, ACSL4 expression appears prominently in specific regions including the cerebellum and hippocampus, consistent with its role in neural development and function[7][30]. The brain-specific ACSL4V2 splice variant further underscores the particular importance of ACSL4 in neural tissue[33]. In the adrenal gland, high ACSL4 expression relates directly to its critical function in steroidogenesis, as discussed subsequently[41]. The expression pattern across tissues reflects the fundamental importance of polyunsaturated fatty acid activation for cell membrane composition, eicosanoid production, and steroid hormone synthesis in these metabolically demanding tissues.</p>
<p>Notably, human cancer tissues and cell lines demonstrate frequently elevated ACSL4 expression, with particularly high levels observed in hepatocellular carcinoma, breast cancer (especially triple-negative breast cancer), colorectal cancer, and head and neck squamous cell carcinoma[1][3][20][32][51]. This cancer-associated upregulation of ACSL4, discussed further in subsequent sections, has prompted investigation of ACSL4 as both a biomarker and potential therapeutic target for malignant tumors.</p>
<h2 id="biological-functions-in-lipid-metabolism">Biological Functions in Lipid Metabolism</h2>
<h3 id="role-in-fatty-acid-activation-and-beta-oxidation">Role in Fatty Acid Activation and Beta-Oxidation</h3>
<p>ACSL4, operating as a critical ligase enzyme, initiates the activation of long-chain fatty acids by catalyzing their conversion to their high-energy fatty acyl-CoA forms, thereby enabling both anabolic and catabolic metabolic pathways[30][31]. In the context of fatty acid degradation, ACSL4 catalyzes the conversion of free fatty acids to activated acyl-CoA molecules that can then enter the mitochondrial matrix for beta-oxidation through action of the carnitine palmitoyltransferase system[18][30][31]. The fatty acyl-CoA then undergoes progressive enzymatic cleavage in two-carbon acetyl units, generating energy molecules including flavine adenine dinucleotide (FADH2) and nicotinamide adenine dinucleotide (NADH)[30]. These energy molecules subsequently participate in the tricarboxylic acid cycle to produce adenosine triphosphate (ATP), the universal cellular energy currency[30]. ACSL4's ability to bind free fatty acids to CoA therefore enables fatty acids to enter the mitochondria and participate in beta-oxidation reactions essential for cellular energy production[30]. The expression level of ACSL4 directly correlates with susceptibility to development of fatty liver disease and various tumors, reflecting its metabolic centrality[30][31].</p>
<h3 id="phospholipid-remodeling-and-membrane-composition">Phospholipid Remodeling and Membrane Composition</h3>
<p>ACSL4 fundamentally regulates phospholipid composition of cellular membranes through its role in incorporating activated polyunsaturated fatty acids into membrane phospholipids[2][4][20][31]. The enzyme catalyzes the conversion of arachidonic acid into arachidonoyl-CoA, which subsequently becomes esterified into phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylcholine (PC) with assistance from lysophosphatidylcholine acyltransferase 3 (LPCAT3)[2][4][20][25][31]. Through this mechanism, ACSL4 promotes the incorporation of polyunsaturated fatty acids into specific phospholipid species, thereby altering the unsaturation profile of cellular membranes[20][25][31].</p>
<p>Recent research has revealed that ACSL4-mediated phospholipid remodeling carries profound consequences for membrane biophysical properties and cellular behavior[20]. In triple-negative breast cancer, ACSL4 upregulation results in increased polyunsaturated phospholipids at the sn-2 position of phosphatidylcholine and phosphatidylethanolamine, compared with primary tumors[20]. This compositional shift increases membrane fluidity and alters lipid-raft organization, thereby modifying the localization and activation of integrin Œ≤1, a critical adhesion molecule regulating tumor metastasis[20]. ACSL4-mediated phospholipid remodeling of the cell membrane induces lipid-raft localization and activation of integrin Œ≤1 in a CD47-dependent manner, which subsequently leads to downstream focal adhesion kinase phosphorylation promoting metastasis[20]. Pharmacologic inhibition of ACSL4 suppressed tumor growth and metastasis while increasing chemosensitivity in TNBC models in vivo, demonstrating the functional importance of ACSL4-mediated membrane remodeling in cancer progression[20].</p>
<h3 id="regulation-of-eicosanoid-and-prostaglandin-biosynthesis">Regulation of Eicosanoid and Prostaglandin Biosynthesis</h3>
<p>ACSL4 plays a sophisticated regulatory role in eicosanoid biosynthesis through its control of arachidonic acid availability and incorporation into membrane phospholipids[9][22][31]. When ACSL4 activity is elevated, the enzyme esterifies arachidonic acid into phospholipids, reducing cellular levels of free (unesterified) arachidonic acid available for conversion into prostaglandins, leukotrienes, and other eicosanoid mediators[1][9][22]. Conversely, when ACSL4 expression is suppressed or inhibited, enhanced arachidonic acid accumulation in the cell promotes its release and conversion into eicosanoids[9][22]. Studies in rodent fibroblastic cells stimulated with interleukin-1Œ≤ and bone marrow-derived macrophages treated with lipopolysaccharide demonstrated that ACSL4 inhibition significantly decreased cellular levels of phosphatidylcholine and phosphatidylinositol species bearing arachidonic acid while simultaneously increasing production of prostaglandin E2 (PGE2), prostaglandin D2, and prostaglandin F2Œ±[9][22]. Notably, sustained downregulation of ACSL4 in human smooth muscle cells led to significant reduction in PGE2 release, whereas short-term ACSL4 inhibition paradoxically increased PGE2 levels, suggesting biphasic or time-dependent regulatory mechanisms[9][22].</p>
<p>The dysregulation of eicosanoid biosynthesis consequent to ACSL4 dysfunction may facilitate inflammatory responses through what researchers term an "eicosanoid storm"‚Äîpathological elevation of multiple eicosanoid mediators driving inflammatory pathology[9][22]. Furthermore, ACSL4 regulates expression of cyclooxygenase-2 (COX-2), the rate-limiting enzyme for prostaglandin synthesis, thereby providing an additional mechanistic explanation for the enhancement in eicosanoids following ACSL4 inhibition[9][22].</p>
<h3 id="steroidogenesis-and-hormone-synthesis">Steroidogenesis and Hormone Synthesis</h3>
<p>ACSL4 participates critically in steroid hormone biosynthesis through provision of activated arachidonic acid required for steroidogenic acute regulatory protein (StAR) gene induction and mitochondrial cholesterol transport[38][41]. In adrenocortical and Leydig cells, arachidonic acid itself and its oxygenase-derived metabolites including epoxyeicosatrienoic acid (EET), 5-hydroxyeicosatetraenoic acid (5-HETE), and 5-hydroperoxyeicosatetraenoic acid can transcriptionally enhance expression and activity of StAR protein, thereby increasing steroid production[22][38][41]. ACSL4 catalyzes the conversion of intracellular free arachidonic acid to arachidonoyl-CoA, which is then provided to steroidogenic tissue for controlled release of arachidonic acid through acyl-CoA thioesterase 2 (ACOT2) pathways[22][25]. The role of ACSL4 in steroidogenesis becomes particularly evident in adrenal cortex cells stimulated with adrenocorticotropin (ACTH), where the hormone-induced increase in intracellular arachidonic acid correlates with ACSL4-mediated conversion and subsequent eicosanoid production that activates the oxoeicosanoid receptor OXER1, leading to enhanced StAR expression and steroid synthesis[38].</p>
<h2 id="the-ferroptosis-paradigm-acsl4-as-a-critical-executor">The Ferroptosis Paradigm: ACSL4 as a Critical Executor</h2>
<h3 id="ferroptosis-as-an-iron-dependent-cell-death-mechanism">Ferroptosis as an Iron-Dependent Cell Death Mechanism</h3>
<p>Ferroptosis represents a recently characterized form of regulated cell death fundamentally distinct from classical apoptosis and necrosis, defined by iron-dependent peroxidation of cellular lipids leading to loss of membrane integrity and ultimate cell death[2][3][10][31][37][40][50]. Unlike apoptosis, which involves activation of caspase enzymes and programmed dismantling of cellular architecture, ferroptosis is driven by accumulation of lipid peroxides in cellular membranes and subcellular organelles, resulting from uncontrolled lipid peroxidation due to loss of antioxidant defenses[2][3][10][31]. The execution of ferroptosis requires multiple molecular events including disruption of iron homeostasis, depletion of the antioxidant defense systems dependent on glutathione (GSH) and glutathione peroxidase 4 (GPX4), and accumulation of reactive oxygen species[2][3][10][31][37].</p>
<p>Within this ferroptotic pathway, ACSL4 and glutathione peroxidase 4 occupy opposing regulatory positions, with ACSL4 positively regulating ferroptosis while GPX4 negatively regulates this cell death process[1][2][31]. The discovery of ACSL4's indispensable role in ferroptosis emerged from genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) genetic screens and microarray analysis studies demonstrating that ACSL4 was significantly downregulated in ferroptosis-resistant cell lines[2][5]. Conversely, ACSL4 knockout cells demonstrated remarkable resistance to ferroptosis induction by RSL3, a potent GPX4 inhibitor and ferroptosis inducer, while ACSL4 overexpression in ferroptosis-resistant cells‚Äîsuch as lymph node carcinoma of the prostate (LNCaP) cells and K562 chronic myelogenous leukemia cells‚Äîsignificantly increased their sensitivity to ferroptosis[5][11].</p>
<h3 id="mechanism-of-acsl4-mediated-lipid-peroxidation">Mechanism of ACSL4-Mediated Lipid Peroxidation</h3>
<p>ACSL4 initiates ferroptosis through a mechanistically well-defined pathway involving generation of lipid peroxides on cellular membranes[2][5][11][31]. To initiate lipid peroxidation, ACSL4 first catalyzes conversion of arachidonic acid into arachidonoyl-CoA, followed by esterification of arachidonoyl-CoA into phosphatidylethanolamine with enzymatic assistance from LPCAT3[2][5][11][31]. The arachidonic acid-containing phosphatidylethanolamine (PE-AA) then undergoes oxidation by lipoxygenase enzymes, particularly 15-lipoxygenase (15-LOX, also designated ALOX15), which catalyzes conversion of the unsaturated fatty acid to its hydroperoxy form (PE-AA-OOH)[2][5][11][25][31]. These lipid hydroperoxides serve as initiating signals for ferroptosis, particularly when cellular levels of the antioxidant enzyme GPX4 and its essential cofactor glutathione prove insufficient to conduct reduction reactions that would otherwise detoxify the lipid hydroperoxides[2][5][11][31].</p>
<p>Adrenic acid (adrenoyl-CoA, AdA-CoA), another long-chain polyunsaturated fatty acid preferentially activated by ACSL4, undergoes similar esterification into phosphatidylethanolamine and subsequent oxidation to form PE-AdA-OOH[2][25][31][51]. Although the concentration of arachidonic acid in the cell membrane remains relatively low at the nanomolar level, ACSL4 exhibits remarkable high specificity and affinity for arachidonic acid, directly determining the concentration of specific ferroptotic lipid peroxides and indirectly influencing cellular sensitivity to ferroptosis[25]. Additional oxidized arachidonic acid-derived metabolites including 5-hydroxyeicosatetraenoic acid (5-HETE) and other hydroxy eicosatetraenoic acid (HETE) derivatives produced through lipoxygenase action on excessive AA-CoA can also contribute to ferroptosis[11][31].</p>
<h3 id="positive-feedback-loop-and-pkcii-acsl4-signaling">Positive Feedback Loop and PKCŒ≤II-ACSL4 Signaling</h3>
<p>Recent mechanistic studies have unveiled a positive-feedback amplification loop in ferroptosis execution involving protein kinase C beta II (PKCŒ≤II) and ACSL4[2][31]. Upon initial activation by slight accumulation of lipid peroxides, phosphorylated and membrane-localized PKCŒ≤II activates ACSL4 through phosphorylation at the Thr328 residue, thereby triggering enhanced PUFA-containing lipid biosynthesis and promoting production of lipid peroxides to lethal levels[2][31]. This positive-feedback mechanism ensures rapid amplification of lipid peroxidation once the ferroptotic process is initiated, essentially converting ACSL4 activation from a basal to a saturated state that irreversibly commits the cell to ferroptotic death.</p>
<h3 id="role-in-autophagy-and-ferroptosis-crosstalk">Role in Autophagy and Ferroptosis Crosstalk</h3>
<p>Established genetic and biochemical evidence indicates that ferroptosis execution requires autophagic machinery including lipophagy (selective autophagy of lipid droplets), clockophagy, ferritinophagy (selective autophagy of ferritin-containing vesicles), and Beclin1 (BECN1)-dependent inhibition of solute carrier family 7 member 11 (SLC7A11)[7][18][30]. The induction of autophagy proves critically dependent on lipid-derived biofilms, especially the endoplasmic reticulum, which requires ACSL4 to perform functions including lipid synthesis and activation[7][18][30]. ACSL4 plays a crucial role in ferroptosis through its function of effectively binding long-chain polyunsaturated fatty acids with coenzyme A, enabling their re-esterification into phospholipids through LPCAT3 action, thereby facilitating promotion of ferroptosis through this autophagy-dependent pathway[7][18][30].</p>
<h2 id="expression-regulation-and-post-translational-modifications">Expression Regulation and Post-Translational Modifications</h2>
<h3 id="transcriptional-regulation">Transcriptional Regulation</h3>
<p>ACSL4 expression is subject to sophisticated transcriptional control through multiple transcription factors and signaling pathways[7][12][19][22][31]. Bioinformatic analysis identified the transcription factor Specificity protein 1 (Sp1) as a key regulator of ACSL4 transcription[19]. The sequence between ‚àí91 and ‚àí101 base pairs upstream in the ACSL4 promoter region binds specifically to Sp1 transcription factor, and Sp1 overexpression enhances ACSL4 levels while Sp1 knockdown reduces ACSL4 expression[19]. This Sp1-mediated transcriptional regulation appears particularly important in inflammatory contexts, as interleukin-1Œ≤ treatment of hepatocellular carcinoma cells significantly increases both Sp1 levels and ACSL4 expression[19]. Dual luciferase reporter assays confirmed the direct binding relationship between Sp1 and the ACSL4 promoter region[19].</p>
<p>In addition to Sp1, several other transcriptional regulators control ACSL4 expression in specific cellular contexts. In triple-negative breast cancer cells, the proximal 43 base pairs at the ACSL4 promoter constitute key regulatory regions responsible for increased ACSL4 expression, with estrogen receptor alpha (ERŒ±) suppressing ACSL4 expression by binding to its promoter[9][22]. This ERŒ±-mediated suppression explains why ERŒ±-positive breast cancers typically exhibit lower ACSL4 expression compared to triple-negative tumors lacking ERŒ±[9][22]. Additional transcriptional activators of ACSL4 include peptidyl arginine deiminase isoform 2, whose silencing downregulates ACSL4 mRNA levels in MCF-7 breast cancer cells[9][22].</p>
<p>In hepatocellular carcinoma, microRNAs serve as suppressors of ACSL4 expression. Specifically, miR-211-5p and miR-205 have been identified as direct suppressors of ACSL4, and both microRNAs show downregulation in HCC with malignant phenotype, resulting in abnormal accumulated cellular cholesterol[9][22][32]. Additionally, apolipoprotein O functions as a potential upstream negative regulator of ACSL4, as evidenced by upregulation of ACSL4 mRNA expression in apolipoprotein O-silenced HepG2 cells[9][22][32]. These diverse transcriptional control mechanisms enable cells to rapidly adjust ACSL4 expression in response to metabolic demands, hormonal signals, and pathological stimuli.</p>
<h3 id="post-translational-modifications-and-kinase-regulation">Post-Translational Modifications and Kinase Regulation</h3>
<p>The activity and cellular function of ACSL4 are extensively regulated through post-translational modifications at both protein and catalytic levels[7][12][30]. Phosphorylation represents a major post-translational modification mechanism regulating ACSL4 function and subcellular localization[7][12][30]. Multiple kinases including protein kinase AMP-activated catalytic subunit (AMPK), protein kinase C beta II (PKCŒ≤II), and protein kinase C (PKC) catalyze phosphorylation of ACSL4, modulating its subcellular localization and receptor recognition, thereby enhancing or inhibiting catalytic activity[7][12][30]. For instance, lactate-rich hepatocellular carcinoma cells exhibit resistance to ferroptosis by promoting ATP production and inactivating AMPK, leading to upregulation of sterol regulatory element-binding protein 1 (SREBP1) and stearoyl-CoA desaturase (SCD), thus enhancing monounsaturated fatty acid production and ferroptosis resistance[12].</p>
<p>Hexokinase 2 (HK2) enhances acetyl-CoA accumulation and promotes H3K27 acetylation modification of the ACSL4 promoter and enhancer regions, thereby inducing ACSL4-dependent fatty acid beta-oxidation and enhancing maintenance and self-renewal of hepatocellular carcinoma stem cells[7]. SHP2 tyrosine phosphatase plays a crucial role in steroidogenesis through a mechanism that includes acyl-CoA synthetase-4, arachidonic acid release, and StAR induction[41][1].</p>
<p>Additional post-translational modifications of ACSL4 include ubiquitination and methylation-dependent regulation. Long noncoding RNA CBSLR (cystathionine beta-synthase-lncRNA) interacts with YTHDF2, an RNA-binding protein recognizing N6-methyladenine (m6A)-modified RNA molecules, thereby regulating RNA degradation, translation, and splicing[7][30]. The interaction between lncRNA-CBSLR and YTHDF2 reduces stability of cystathionine beta-synthase (CBS) mRNA, which in turn leads to decreased ACSL4 methylation, protein polyubiquitination, and subsequent degradation[7][30]. Although these findings provide new insights into ACSL4 regulatory mechanisms, the specific methylation enzymes and modification sites for ACSL4 require further investigation[7][30].</p>
<h2 id="disease-associations-and-clinical-implications">Disease Associations and Clinical Implications</h2>
<h3 id="cancer-biology-and-paradoxical-roles">Cancer Biology and Paradoxical Roles</h3>
<p>ACSL4 demonstrates profoundly context-dependent and tissue-specific roles in cancer biology, functioning as either a tumor promoter or tumor suppressor depending on cancer type and molecular subtype[32][48][51][54]. In hepatocellular carcinoma, elevated ACSL4 expression promotes disease progression through multiple interconnected mechanisms including upregulation of the master lipogenesis regulator SREBP1 via a c-Myc-dependent pathway, driving aberrant accumulation of intracellular lipid components and HCC progression[9][22][31][32][51]. ACSL4 prevents the degradation of c-Myc, which transcriptionally upregulates SREBP1, thereby promoting downstream lipogenic enzymes[9][22][32]. In addition, ACSL4 depletion decreases phosphorylation of extracellular signal-regulated kinase (ERK), which directly destabilizes c-Myc or indirectly promotes ubiquitin-dependent degradation of c-Myc through increased expression of F-box and WD repeat domain-containing 7 (FBW7) E3 ligase[9][22][32]. ACSL4 also activates the mammalian target of rapamycin (mTOR) signaling pathway, controlling multiple metabolic programs including glycolysis, glutaminolysis, and fatty acid oxidation that support endless energy demands of cancer cells[9][22].</p>
<p>In breast cancer, particularly triple-negative breast cancer, ACSL4 upregulation drives pro-metastatic phospholipid remodeling through mechanisms detailed above[20]. However, in estrogen receptor-positive breast cancer, ACSL4 expression inhibits cancer cell proliferation, suggesting that the estrogen receptor status fundamentally determines the functional consequence of ACSL4 expression in breast tumors[32][51]. The high ACSL4 expression in triple-negative breast cancer associated with poor prognosis contrasts with its apparent tumor-suppressive role in ER-positive breast cancer, exemplifying the tissue- and context-specific nature of ACSL4 function[32][51].</p>
<p>In lung adenocarcinoma, comprehensive cancer genome atlas analysis revealed that ACSL4 is frequently downregulated, and Kaplan-Meier survival analysis demonstrated that patients with lower ACSL4 expression exhibited worse progression-free survival and overall survival compared to patients with higher ACSL4 expression[51]. In these lung cancer cells, knockdown of ACSL4 improved tumor invasiveness and inhibited ferroptosis, while ACSL4 overexpression demonstrated opposite effects[32][51]. This tumor-suppressive role appears mediated through ferroptosis induction, positioning ACSL4 as a ferroptosis-mediating protective factor in lung cancer[32][51].</p>
<p>In colorectal cancer, higher ACSL4 expression correlates with increased colorectal cancer cell proliferation, migration, and shorter patient survival[32][51]. KRAS mutant colorectal cancer cell lines demonstrate significant upregulation of ACSL4 compared to KRAS wild-type cells, and specific shRNA knockout of ACSL4 inhibited erastin-induced ferroptosis in KRAS mutant DLD-1 cells[32][51]. In hepatocellular carcinoma, patients with complete or partial response to sorafenib demonstrated higher ACSL4 expression, with ACSL4 levels negatively correlating with half-maximal inhibitory concentration values for sorafenib[9][22][32]. Further knockdown of ACSL4 significantly abolished sorafenib-induced ferroptotic cancer cell death and tumor growth inhibition[9][22][32]. Elevation of ACSL4 thus appears to enhance sorafenib sensitivity through ferroptosis promotion, suggesting potential therapeutic utility in improving HCC treatment outcomes[9][22][32].</p>
<h3 id="intellectual-disability-and-x-linked-inheritance">Intellectual Disability and X-Linked Inheritance</h3>
<p>ACSL4 mutations and deletions constitute recognized causes of non-syndromic and syndromic X-linked intellectual disability (XLID)[1][14][17][42]. The most thoroughly characterized clinical association involves a contiguous gene deletion syndrome affecting chromosome Xq22.3 that encompasses multiple genes including both COL4A5 and ACSL4[14]. Families with this condition present with intellectual disability accompanied by Alport syndrome, characterized by progressive glomerulonephritis and sensorineural hearing loss due to mutations in COL4A5 encoding type IV collagen[14]. Analysis of affected males revealed functional nullisomy of ACSL4 (complete absence of functional protein) despite presence of a truncated 54 kDa protein product, indicating that the truncated protein lacks enzymatic activity[14]. The clinical phenotype in these families consistently includes intellectual disability with absent or severely delayed speech, midface hypoplasia, and facial hypotonia, features observed uniformly in the absence of functional ACSL4 gene[14].</p>
<p>The high expression of ACSL4 in brain tissue, particularly in the cerebellum and hippocampus‚Äîcritical regions for learning and memory[7][30]‚Äîcombined with the brain-specific ACSL4V2 splice variant[8][33], establishes the molecular basis for neurological manifestations of ACSL4 mutations. Mutations affecting both ACSL4V1 and ACSL4V2 transcripts appear particularly deleterious, as these would eliminate ACSL4 function in both brain and other tissues[8][33]. The identification of ACSL4 mutations as a cause of X-linked intellectual disability raised the possibility of using ACSL4 mutation analysis as an efficient diagnostic tool in males with intellectual disability[14], though such screening remains underutilized in contemporary clinical practice.</p>
<h3 id="neurodegenerative-diseases-and-ischemic-injury">Neurodegenerative Diseases and Ischemic Injury</h3>
<p>Recent research has firmly established ferroptosis as a pathological mechanism contributing to neuronal death in major neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, and Huntington's disease[26][37][40][50]. In Parkinson's disease specifically, the substantia nigra and striatum accumulate both iron and polyunsaturated fatty acids, creating conditions predisposing to ferroptosis[26]. Studies in dopaminergic neurons demonstrated that modification of the PUFA composition in neuronal membranes using arachidonic acid determines ferroptosis susceptibility, and cotreatment with iron synergistically promotes high lipid peroxidation facilitating ferroptosis[26]. Prevention of ferroptotic AA + Fe-induced cell death through inhibition of ACSL4, ALOX15 (15-lipoxygenase), or ALOX15B provided mechanistic support for lipid peroxidation pathway involvement in dopaminergic neuronal death[26]. These findings position ACSL4 inhibitors as potential neuroprotective agents with novel therapeutic potential for Parkinson's disease and related neurodegenerative conditions[26][40][50].</p>
<p>In the context of cerebral ischemia-reperfusion injury, ferroptosis-mediated tissue injury becomes exacerbated following stroke due to restoration of blood flow initiating cascades of detrimental events disrupting cellular homeostasis and causing cell death[50][53]. Upregulation of ACSL4 following ischemic stroke initiates heightened accumulation of lipid peroxidation products and reactive oxygen species, thereby exacerbating ferroptotic progression in neuronal cells[50]. Because brain tissue is particularly rich in polyunsaturated fatty acids‚Äîparticularly arachidonic acid‚Äîtargeting ACSL4 to inhibit ferroptosis represents an effective approach to alleviate brain injuries including stroke[50]. Rosiglitazone, a thiazolidinedione antidiabetic agent, demonstrates ACSL4 inhibitory properties independent of peroxisome proliferator-activated receptor gamma (PPAR-Œ≥) binding[52]. Administration of rosiglitazone significantly reduced neuronal necrosis, iron deposition, brain water content, and reactive oxygen species in brain tissue following surgical brain injury while ameliorating neurological deficits, effects concomitant with decreased transferrin expression and ACSL4 upregulation[49].</p>
<h3 id="inflammatory-and-fibrotic-disease">Inflammatory and Fibrotic Disease</h3>
<p>Recent studies have implicated ACSL4-mediated ferroptosis in inflammatory macrophage activation and fibrosis progression in systemic sclerosis (SSc)[43]. Both skin and lung tissue ferroptosis with enhanced ACSL4 expression occur in SSc mice, while ACSL4 inhibition effectively halted fibrosis progression and provided protection from inflammatory microenvironment[43]. A positive regulation relationship emerged between LPS-induced macrophage activation level and ferroptosis sensitivity, with calpain proteases functioning as potential upstream regulators of ACSL4[43]. After calpain knockdown, both inflammatory macrophage ferroptosis sensitivity and ACSL4 expression decreased, whereas calpain overexpression rendered ACSL4-upregulating conditions[43]. Calpain pharmacological inhibition reduced both ferroptosis and fibrosis aptitude in systemic sclerosis mice models[43].</p>
<p>Additionally, ACSL4 mediates inflammatory bowel disease and contributes to LPS-induced intestinal epithelial cell dysfunction by activating ferroptosis[46]. Research findings demonstrated marked increase in ACSL4 gene expression in inflamed intestinal tissues of patients with Crohn's disease and ulcerative colitis compared to non-inflamed intestinal tissues[46]. The inflammatory response appears to activate ACSL4 expression during IBD advancement[46]. Treatment with LPS at concentrations of 1 or 10 Œºg/mL resulted in significant upregulation of ACSL4, GPX4, and SLC7A11 gene expression in Caco-2 intestinal epithelial cells, with LPS-induced decrease in cell viability reversed by ACSL4 silencing or rosiglitazone treatment[46].</p>
<h2 id="therapeutic-targeting-and-drug-development">Therapeutic Targeting and Drug Development</h2>
<h3 id="small-molecule-acsl4-inhibitors">Small Molecule ACSL4 Inhibitors</h3>
<p>Given ACSL4's critical roles in ferroptosis regulation and diverse pathological conditions, development of small molecule inhibitors targeting ACSL4 represents an active area of therapeutic research[10][15][32][37][40][49][50][53]. Rosiglitazone, a thiazolidinedione antidiabetic agent initially developed for glucose homeostasis, demonstrated unexpected ACSL4 inhibitory properties independent of PPAR-Œ≥ receptor activation[52]. Rosiglitazone directly inhibits ACSL activity in human and murine arterial smooth muscle cells and human macrophages expressing ACSL4, while demonstrating no effect in murine macrophages lacking ACSL4 expression[52]. The inhibitory mechanism involves acute suppression of fatty acid partitioning into phospholipids in human smooth muscle cells and inhibition of partitioning into diacylglycerol and triacylglycerol in human smooth muscle cells and macrophages[52]. Beyond its ACSL4-inhibitory properties, rosiglitazone demonstrates broad pharmacological effects on metabolic regulation and immune function, complicating interpretation of results in animal models and clinical applications.</p>
<p>Other ferroptosis inhibitors targeting ACSL4 include ferrostatin-1 and liproxstatin-1, which suppress ferroptosis through multiple mechanisms[37][40]. Studies in Parkinson's disease models using LUHMES dopaminergic cells demonstrated that RSL3-induced ferroptosis could be blocked by ACSL4 inhibitors (such as troglitazone), ALOX15/15B inhibitors (such as PD 146176, baicalein), and siRNAs targeting ACSL4, ALOX15, and ALOX15B[37]. These findings identified multiple druggable nodes within the ferroptosis pathway, with ACSL4 representing a particularly attractive target given its essential role in ferroptotic lipid peroxidation substrate generation.</p>
<h3 id="immunotherapy-and-cd8-t-cell-function">Immunotherapy and CD8+ T Cell Function</h3>
<p>Recent discoveries have unveiled unexpected roles for ACSL4 in tumor immunity and the effectiveness of immunotherapy approaches[32][51]. Interferon-gamma (IFN-Œ≥) secreted by CD8+ T cells, together with arachidonic acid, can promote ACSL4-mediated ferroptosis in tumor cells, representing a mode of action for cytotoxic T lymphocyte-mediated tumor killing[32][51]. IFN-Œ≥ stimulates ACSL4 expression and changes the lipid pattern of tumor cells, thereby increasing binding of arachidonic acid to C16 and C18 acyl-chain-containing phospholipids[32][51]. Genetic deletion of ACSL4 resulted in impaired anti-tumor CD8+ T cell responses, suggesting that ACSL4 expression in tumor cells may be necessary for effective immune-mediated tumor suppression[32][51]. These findings provide mechanistic insights into how the metabolic and immune milieu could be leveraged to promote ferroptosis as a mode of tumor immunotherapy, suggesting that enhancing ACSL4 expression might sensitize tumors to immune checkpoint inhibitors and other immunotherapies.</p>
<h3 id="natural-compounds-and-multi-target-therapeutics">Natural Compounds and Multi-Target Therapeutics</h3>
<p>Beyond synthetic small molecules, natural compounds have emerged as promising candidates for targeting ferroptosis and ACSL4[37][40]. Œ≤-hydroxybutyric acid, a ketone body with neuroprotective effects demonstrated in Parkinson's disease models, upregulates zinc finger protein 36, which facilitates binding and degradation of ACSL4 mRNA, thereby reducing ACSL4 protein levels[37]. This natural metabolite's ability to suppress ACSL4 through post-transcriptional mechanisms offers an intriguing nutritional or metabolic approach to ferroptosis modulation. The recent surge in ferroptosis-focused drug development (reflected in active clinical trials such as NCT06890741) indicates the field's recognition of ferroptosis modulation as a promising therapeutic strategy with potential applications across multiple disease categories[48].</p>
<h2 id="recent-developments-and-future-perspectives-2023-2025">Recent Developments and Future Perspectives (2023-2025)</h2>
<h3 id="current-understanding-of-acsl4-biology">Current Understanding of ACSL4 Biology</h3>
<p>As of 2025, the understanding of ACSL4 biology has evolved significantly from its initial characterization as a simple fatty acid activation enzyme to recognition as a metabolic hub integrating ferroptosis, immune function, cancer metabolism, and tissue injury responses[10][15][29][48][54]. The 2025 Frontiers in Pharmacology review article "ACSL4 at the Helm of the Lipid Peroxidation Ship: A Deep-Sea Exploration Towards Ferroptosis" synthesized current knowledge, emphasizing ACSL4's role as a critical determinant of cellular susceptibility to ferroptosis through its control of lipid peroxidation substrate availability[10][15][29]. The expression level or enzymatic activity of ACSL4 emerges as a potential indicator of cellular susceptibility to ferroptosis, with implications for predicting therapeutic responsiveness and developing personalized medicine approaches[10][15][29].</p>
<p>The paradoxical roles of ACSL4 in different cancer types‚Äîfunctioning as both tumor promoter and tumor suppressor depending on cellular context‚Äîremain a significant challenge for clinical translation[32][48][54]. Current research indicates that ACSL4 operates through multifaceted and multi-directional regulatory mechanisms that extend beyond simple ferroptosis induction, encompassing lipid metabolic reprogramming, immune cell regulation, drug resistance mechanisms, and signaling pathway activation[32][48][54]. Determining how to balance these roles and develop therapeutic strategies that selectively target pro-tumorigenic ACSL4 functions while preserving anti-tumorigenic ferroptosis-promoting activities represents a critical issue requiring further in-depth investigation[32][48][54].</p>
<h3 id="emerging-areas-of-investigation">Emerging Areas of Investigation</h3>
<p>Recent studies have identified previously unrecognized aspects of ACSL4 biology warrant further investigation. The role of ACSL4 in immune cell metabolism and CD8+ T cell function represents a frontier for understanding how ACSL4 contributes to effective anti-tumor immunity[32][51]. The involvement of ACSL4 in neuroinflammation and microglia activation, potentially contributing to neurodegeneration and post-stroke inflammation, offers new therapeutic opportunities beyond direct ferroptosis modulation[37][40][50][53]. The increasingly recognized connections between ACSL4, mitochondrial-associated membranes, and mitochondrial dynamics suggest that ACSL4's role in regulating ER-mitochondrial communication may have broader implications for cellular bioenergetics and stress responses than currently appreciated[44][47][54].</p>
<p>The discovery of ACSL4 involvement in intestinal barrier function and inflammatory bowel disease through ferroptosis-dependent mechanisms opens new avenues for therapeutic intervention in these prevalent and poorly controlled conditions[46]. Similarly, the emerging evidence for ACSL4's role in systemic sclerosis and fibrosis progression through ferroptosis regulation suggests potential therapeutic applications in progressive fibrotic diseases[43].</p>
<h2 id="conclusion">Conclusion</h2>
<p>ACSL4 represents a sophisticated metabolic enzyme whose biological significance far transcends its canonical classification as a simple fatty acid activation enzyme. The gene product catalyzes the ATP-dependent conversion of long-chain polyunsaturated fatty acids‚Äîmost notably arachidonic acid‚Äîinto their high-energy acyl-CoA derivatives, a reaction of fundamental importance for both cellular lipid biosynthesis and catabolic fatty acid oxidation[1][2][31]. The exceptional substrate specificity of ACSL4 for arachidonic acid, with approximately 10 to 300-fold higher catalytic efficiency than other ACSL family members, positions this enzyme as a dedicated regulator of arachidonic acid metabolism in cells[8][24]. Through its role in phospholipid remodeling, eicosanoid biosynthesis, and steroid hormone production, ACSL4 governs multiple physiological processes essential for cellular and organismal function[2][22][31][38][41].</p>
<p>More recently, ACSL4 has emerged as an indispensable executor of ferroptosis, an iron-dependent form of regulated cell death with profound implications for both pathological disease states and potential therapeutic intervention[2][3][10][31][37][40][50]. The generation of lipid peroxidation substrates through ACSL4-mediated phospholipid remodeling, coupled with the enzyme's remarkable substrate specificity for arachidonic acid, establishes ACSL4 as the critical bottleneck controlling cellular susceptibility to ferroptotic death[2][25][31]. The positive-feedback loop involving PKCŒ≤II phosphorylation of ACSL4 at Thr328, triggering amplification of lipid peroxidation once ferroptosis is initiated, represents a sophisticated regulatory mechanism ensuring irreversible commitment to ferroptotic death once this pathway is engaged[2][31].</p>
<p>The paradoxical and context-dependent roles of ACSL4 in cancer biology‚Äîfunctioning as both tumor accelerator in some malignancies (hepatocellular carcinoma, triple-negative breast cancer, colorectal cancer) and tumor suppressor in others (lung adenocarcinoma, ovarian cancer)‚Äîexemplify the complexity of translating molecular discoveries into effective clinical therapeutics[32][48][51][54]. The mechanistic basis for this cancer-type-specific dichotomy likely relates to the balance between pro-tumorigenic lipid metabolic reprogramming and pro-death ferroptotic induction, with the dominant phenotypic outcome varying depending on the specific oncogenic drivers, immune microenvironment, and metabolic context of each tumor type[32][48][51][54].</p>
<p>The X-linked inheritance of ACSL4 and its involvement in syndromic and non-syndromic intellectual disability[14][17][42] underscores the particular importance of ACSL4 for neural development and function. The high abundance of ACSL4 in the brain, combined with the brain-specific ACSL4V2 splice variant[8][33], emphasizes the critical role of this enzyme in maintaining neural cellular architecture and function. The emerging recognition of ACSL4's role in neurodegenerative disease pathogenesis through ferroptosis-mediated mechanisms[26][37][40][50] suggests that ACSL4 inhibitors may provide neuroprotective benefits in conditions ranging from Parkinson's disease to stroke and Alzheimer's disease.</p>
<p>Looking forward, the therapeutic development landscape surrounding ACSL4 appears extraordinarily promising yet simultaneously complex. The identification of multiple small molecule inhibitors targeting ACSL4, including rosiglitazone and various ferroptosis inhibitors[37][40][49][50][52], demonstrates feasibility of pharmacological ACSL4 inhibition. However, the context-dependent and tissue-specific roles of ACSL4 necessitate careful consideration of when ACSL4 inhibition represents a beneficial therapeutic strategy versus when ACSL4 activation might be therapeutically desirable. Future research must focus on developing selective therapeutic approaches that leverage ACSL4's pro-ferroptotic, anti-tumorigenic functions in appropriate cancer contexts while exploiting ACSL4 inhibition to prevent pathological ferroptosis in neurodegenerative and ischemic injury conditions. The emerging understanding of ACSL4's role in immune cell metabolism and anti-tumor immunity offers additional opportunities for therapeutic synergy with immunotherapy approaches. Ultimately, ACSL4 emerges as a paradigmatic example of a metabolic enzyme whose functional complexity extends far beyond its elemental enzymatic activity, operating as a central regulatory node integrating lipid metabolism, ferroptotic cell death, immune function, and disease pathogenesis across multiple organ systems and disease contexts.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://en.wikipedia.org/wiki/ACSL4</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10617883/</li>
<li>https://maayanlab.cloud/Harmonizome/gene/ACSL4</li>
<li>https://pubmed.ncbi.nlm.nih.gov/37442770/</li>
<li>https://mednexus.org/doi/abs/10.1097/CM9.0000000000002533</li>
<li>https://www.ncbi.nlm.nih.gov/gene/2182</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10295397/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/31061331/</li>
<li>https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1594419/full</li>
<li>https://mednexus.org/doi/10.1097/CM9.0000000000002533</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6182735/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/20186809/</li>
<li>https://www.proteinatlas.org/ENSG00000068366-ACSL4/subcellular</li>
<li>https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.35778</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10007726/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11148537/</li>
<li>https://www.proteinatlas.org/ENSG00000068366-ACSL4</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3037030/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12417525/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/36581060/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3593989/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5506843/</li>
<li>https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.949863/full</li>
<li>https://www.jstage.jst.go.jp/article/bpb/42/5/42_b19-00085/_html/-char/ja</li>
<li>https://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fctd2.200</li>
<li>https://blog.cellsignal.com/hallmarks-of-cancer-resisting-cell-death</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9998952/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12689422/</li>
<li>https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1175677/full</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8685280/</li>
<li>https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1683876/full</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4899475/</li>
<li>https://www.neurology.org/doi/10.1212/WNL.92.15_supplement.P5.6-038</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10601156/</li>
<li>https://www.science.org/doi/10.1126/sciadv.abo1244</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3322227/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11377980/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7902067/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12647431/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/37675456/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11961533/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/17259370/</li>
<li>https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1613464/full</li>
<li>https://www.liebertpub.com/doi/10.1089/ars.2023.0237</li>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACSL4</li>
<li>https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.673647/full</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: O60488
gene_symbol: ACSL4
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &#39;ACSL4 (Long-chain-fatty-acid--CoA ligase 4) is a membrane-associated
  enzyme that catalyzes the ATP-dependent activation of long-chain polyunsaturated
  fatty acids (PUFAs) by ligating them to coenzyme A. The enzyme shows strong substrate
  preference for arachidonic acid (AA, 20:4) and adrenic acid (AdA, 22:4), forming
  AA-CoA and AdA-CoA. These PUFA-CoA products are incorporated into membrane phospholipids
  (particularly phosphatidylethanolamine) by LPCAT3, where they become substrates
  for lipid peroxidation. ACSL4 is a critical positive regulator of ferroptosis, an
  iron-dependent form of regulated cell death driven by lipid peroxidation. ACSL4
  is localized primarily to the endoplasmic reticulum membrane, with additional presence
  at mitochondrial outer membrane, ER-mitochondria contact sites (MAM), plasma membrane,
  and lipid droplets. Mutations in ACSL4 cause X-linked intellectual disability (XLID63).
  EC numbers: 6.2.1.3 (long-chain fatty acid-CoA ligase) and 6.2.1.15 (arachidonate-CoA
  ligase).&#39;
existing_annotations:
- term:
    id: GO:0001676
    label: long-chain fatty acid metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 is directly involved in long-chain fatty acid metabolism by activating
      long-chain PUFAs through ATP-dependent ligation to CoA. This is a core function
      supported by extensive experimental evidence (PMID:9598324, PMID:21242590, PMID:22633490,
      PMID:24269233).
    action: ACCEPT
    reason: This annotation accurately reflects ACSL4&#39;s core enzymatic role. The enzyme
      catalyzes the conversion of long-chain fatty acids to their active acyl-CoA
      forms, which is the first step in both lipid synthesis and degradation pathways
      (PMID:21242590).
    supported_by:
    - reference_id: PMID:21242590
      supporting_text: Long-chain acyl-CoA synthetases (ACSLs) catalyze the thioesterification
        of long-chain FAs into their acyl-CoA derivatives
    - reference_id: PMID:9598324
      supporting_text: The cDNA encodes a functional long-chain fatty acid-CoA ligase
        that shows preference for arachidonic acid as substrate
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 localizes to the endoplasmic reticulum, which is its primary site
      of action for lipid metabolism and ferroptosis-related PUFA-CoA generation.
      Deep research confirms ER as the predominant localization site.
    action: ACCEPT
    reason: ER localization is well-established and represents a core site for ACSL4
      function. The enzyme operates at ER oxidation centers crucial for phospholipid
      remodeling and ferroptosis execution. PMID:24269233 confirms ER localization.
    supported_by:
    - reference_id: PMID:24269233
      supporting_text: All 8 ACSs were localized either exclusively or partly to the
        endoplasmic reticulum (ER), where S1P metabolism takes place
- term:
    id: GO:0030182
    label: neuron differentiation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 mutations cause X-linked intellectual disability (XLID63), suggesting
      a role in neuronal function. However, neuron differentiation is likely a pleiotropic/peripheral
      function rather than a core enzymatic function.
    action: KEEP_AS_NON_CORE
    reason: While ACSL4 is expressed in brain and mutations cause intellectual disability
      (PMID:11889465), the primary function of ACSL4 is fatty acid-CoA ligation. Neuronal
      effects are likely downstream consequences of altered lipid metabolism rather
      than direct involvement in differentiation pathways. The IBA annotation reflects
      phylogenetic inference from other family members.
    supported_by:
    - reference_id: PMID:11889465
      supporting_text: FACL4 is the first gene shown to be involved in nonspecific
        mental retardation and fatty-acid metabolism
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 has been reported at the plasma membrane in addition to ER and
      mitochondrial membranes. UniProt confirms cell membrane localization.
    action: ACCEPT
    reason: Plasma membrane localization is supported by UniProt annotation (PMID:24269233)
      and is consistent with ACSL4&#39;s role in membrane phospholipid remodeling. Multiple
      membrane localizations are expected for this enzyme.
    supported_by:
    - reference_id: PMID:24269233
      supporting_text: we cloned all 26 human ACS genes and examined their abilities
        to restore deficient sphingolipid-to-glycerophospholipid metabolism
- term:
    id: GO:0005811
    label: lipid droplet
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 localizes to lipid droplets, consistent with its role in fatty
      acid activation for lipid synthesis and storage.
    action: ACCEPT
    reason: Lipid droplet localization is confirmed by mass spectrometry identification
      in the lipid droplet-enriched fraction from HuH7 cells (PMID:14741744). This
      localization makes functional sense given ACSL4&#39;s role in fatty acid activation
      for triglyceride and phospholipid synthesis.
    supported_by:
    - reference_id: PMID:14741744
      supporting_text: 17 major proteins in the fraction were identified using nano
        LC-MS/MS techniques... Included in the identified proteins were five lipid-metabolizing
        enzymes
- term:
    id: GO:0035336
    label: long-chain fatty-acyl-CoA metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 directly produces long-chain fatty acyl-CoAs from free fatty acids,
      making this a core function.
    action: ACCEPT
    reason: This annotation accurately describes ACSL4&#39;s primary enzymatic output.
      The enzyme generates long-chain fatty acyl-CoAs (particularly AA-CoA and AdA-CoA)
      which are the direct products of its catalytic activity (PMID:31061331, PMID:21242590).
    supported_by:
    - reference_id: PMID:31061331
      supporting_text: Acyl-CoA synthetase long-chain family members (ACSLs) are a
        family of enzymes that convert long-chain free fatty acids into their acyl-CoAs
- term:
    id: GO:0047676
    label: arachidonate-CoA ligase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: ACSL4 shows strong preference for arachidonic acid as substrate, catalyzing
      its conversion to arachidonoyl-CoA. This is a core molecular function.
    action: ACCEPT
    reason: Arachidonate-CoA ligase activity (EC 6.2.1.15) is experimentally validated
      as a core function of ACSL4 (PMID:9598324, PMID:21242590, PMID:31061331). UniProt
      lists this as an established EC number for ACSL4.
    supported_by:
    - reference_id: PMID:9598324
      supporting_text: The cDNA encodes a functional long-chain fatty acid-CoA ligase
        that shows preference for arachidonic acid as substrate
    - reference_id: PMID:31061331
      supporting_text: ACSL4 is an ACSL isozyme with a strong preference for arachidonic
        acid (AA)
- term:
    id: GO:0000166
    label: nucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: ACSL4 requires ATP for its catalytic activity. The annotation to &#39;nucleotide
      binding&#39; is too general - the specific function is ATP binding.
    action: MARK_AS_OVER_ANNOTATED
    reason: While technically correct that ACSL4 binds nucleotides (specifically ATP),
      this term is too general and does not capture the specific ATP requirement for
      the adenylation reaction. The more specific GO:0005524 (ATP binding) annotation
      exists and is preferred.
    proposed_replacement_terms:
    - id: GO:0005524
      label: ATP binding
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This is the core molecular function of ACSL4, accurately annotated by
      electronic inference. Extensively validated by experimental evidence.
    action: ACCEPT
    reason: Long-chain fatty acid-CoA ligase activity (EC 6.2.1.3) is the primary
      enzymatic function of ACSL4. This IEA annotation is consistent with multiple
      experimental studies (PMID:21242590, PMID:22633490, PMID:24269233, PMID:31061331).
    supported_by:
    - reference_id: PMID:21242590
      supporting_text: Purified ACSL4 is an arachidonic acid (20:4)-preferring ACSL
        isoform
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: ACSL4 requires ATP for its adenylation-thiolation reaction mechanism.
      ATP binding is essential for catalysis.
    action: ACCEPT
    reason: ATP binding is required for the ACSL4 catalytic mechanism, where fatty
      acids are first adenylated before transfer to CoA. The enzyme belongs to the
      ATP-dependent AMP-binding enzyme family (UniProt annotation).
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: Belongs to the ATP-dependent AMP-binding enzyme family
- term:
    id: GO:0005741
    label: mitochondrial outer membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: ACSL4 localizes to the mitochondrial outer membrane, a confirmed localization
      site supported by experimental evidence.
    action: ACCEPT
    reason: Mitochondrial outer membrane localization is confirmed by UniProt subcellular
      location annotation and supported by IDA evidence (PMID:38720107). This is a
      Type III membrane protein topology.
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: &#39;SUBCELLULAR LOCATION: Mitochondrion outer membrane&#39;
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: ACSL4 is an integral membrane protein of the ER membrane, its primary
      site of function.
    action: ACCEPT
    reason: ER membrane localization is well-established as the primary site for ACSL4
      function in phospholipid remodeling and ferroptosis (PMID:24269233, UniProt
      annotation).
    supported_by:
    - reference_id: PMID:24269233
      supporting_text: All 8 ACSs were localized either exclusively or partly to the
        endoplasmic reticulum (ER)
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: Duplicate annotation to plasma membrane (also annotated by IBA). ACSL4
      is found at plasma membrane in addition to ER and mitochondria.
    action: ACCEPT
    reason: Plasma membrane localization is supported by UniProt subcellular location
      annotation. Having both IBA and IEA evidence strengthens this annotation.
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: &#39;SUBCELLULAR LOCATION: Mitochondrion outer membrane&#39;
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: ACSL4 is involved in lipid metabolism through fatty acid activation.
      However, this term is too general - more specific terms are available.
    action: MARK_AS_OVER_ANNOTATED
    reason: While technically correct, &#39;lipid metabolic process&#39; is too broad. ACSL4&#39;s
      specific role is in long-chain fatty acid metabolism and fatty acyl-CoA biosynthesis.
      The more specific GO:0001676 (long-chain fatty acid metabolic process) annotation
      already exists and better captures ACSL4&#39;s function.
    proposed_replacement_terms:
    - id: GO:0001676
      label: long-chain fatty acid metabolic process
    - id: GO:0035338
      label: long-chain fatty-acyl-CoA biosynthetic process
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: ACSL4 is involved in fatty acid metabolism. This is correct but less
      specific than other available annotations.
    action: ACCEPT
    reason: Fatty acid metabolic process is appropriate as a broader annotation that
      captures ACSL4&#39;s general role. The more specific GO:0001676 provides additional
      specificity. Both annotations can coexist.
    supported_by:
    - reference_id: PMID:9598324
      supporting_text: Long-chain fatty acid-CoA ligase (also called fatty acid acyl-CoA
        synthetase) plays an essential role in lipid biosynthesis and fatty acid degradation
- term:
    id: GO:0016874
    label: ligase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: ACSL4 has ligase activity, but this term is too general - the specific
      function is long-chain fatty acid-CoA ligase activity.
    action: MARK_AS_OVER_ANNOTATED
    reason: &#39;&#39;&#39;Ligase activity&#39;&#39; is too broad and uninformative. The specific GO:0004467
      (long-chain fatty acid-CoA ligase activity) annotation exists and should be
      preferred.&#39;
    proposed_replacement_terms:
    - id: GO:0004467
      label: long-chain fatty acid-CoA ligase activity
- term:
    id: GO:0047676
    label: arachidonate-CoA ligase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Duplicate annotation (also IBA). ACSL4 has arachidonate-CoA ligase activity
      as a core function.
    action: ACCEPT
    reason: This core molecular function is well-established experimentally (PMID:9598324,
      PMID:31061331). The IEA annotation is consistent with experimental evidence.
    supported_by:
    - reference_id: PMID:9598324
      supporting_text: shows preference for arachidonic acid as substrate
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: ACSL4 localizes to mitochondria, specifically the outer membrane. This
      annotation is correct but less specific than GO:0005741 (mitochondrial outer
      membrane).
    action: ACCEPT
    reason: Mitochondrial localization is supported by UniProt and experimental evidence.
      While GO:0005741 (mitochondrial outer membrane) is more specific, both annotations
      are valid and reflect the true localization.
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: Mitochondrion outer membrane
- term:
    id: GO:0006633
    label: fatty acid biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation is misleading. ACSL4 does not participate in de novo
      fatty acid biosynthesis. It activates existing fatty acids for esterification
      into complex lipids.
    action: MODIFY
    reason: ACSL4 activates fatty acids by CoA ligation, which is a step in fatty
      acid utilization (for phospholipid synthesis or beta-oxidation), NOT de novo
      fatty acid biosynthesis. De novo fatty acid synthesis involves FAS complex and
      elongases. This annotation likely arose from confusion between activation and
      biosynthesis. The correct process term should be GO:0035338 (long-chain fatty-acyl-CoA
      biosynthetic process).
    proposed_replacement_terms:
    - id: GO:0035338
      label: long-chain fatty-acyl-CoA biosynthetic process
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-434313
  review:
    summary: Reactome pathway R-HSA-434313 (Intracellular metabolism of fatty acids
      regulates insulin secretion) includes ACSL4 in fatty acid metabolism.
    action: ACCEPT
    reason: ACSL4 is involved in fatty acid metabolism as part of the insulin secretion
      regulatory pathway. While insulin secretion regulation is a peripheral function,
      the fatty acid metabolism annotation itself is accurate.
    supported_by:
    - reference_id: Reactome:R-HSA-434313
      supporting_text: Intracellular metabolism of fatty acids regulates insulin secretion
- term:
    id: GO:0035338
    label: long-chain fatty-acyl-CoA biosynthetic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-75876
  review:
    summary: ACSL4 catalyzes the biosynthesis of long-chain fatty acyl-CoAs. This
      is a core function annotation.
    action: ACCEPT
    reason: Long-chain fatty-acyl-CoA biosynthetic process accurately describes ACSL4&#39;s
      enzymatic output. The enzyme synthesizes acyl-CoA from free fatty acids, ATP,
      and CoA (PMID:21242590, PMID:31061331).
    supported_by:
    - reference_id: Reactome:R-HSA-75876
      supporting_text: Synthesis of very long-chain fatty acyl-CoAs
- term:
    id: GO:0090433
    label: palmitoyl-CoA ligase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-434382
  review:
    summary: ACSL4 can use palmitate as substrate but it is not a preferred substrate.
      ACSL4 preferentially activates PUFAs (AA, AdA) over saturated fatty acids like
      palmitate.
    action: KEEP_AS_NON_CORE
    reason: UniProt confirms ACSL4 can catalyze palmitate activation (hexadecanoate
      + ATP + CoA reaction), but this is not ACSL4&#39;s preferred activity. ACSL4 shows
      marked preference for polyunsaturated fatty acids (AA, AdA) over saturated fatty
      acids (PMID:31061331, PMID:21242590). Palmitoyl-CoA ligase activity is secondary
      to the PUFA-specific functions.
    supported_by:
    - reference_id: PMID:31061331
      supporting_text: ACSL4 is an ACSL isozyme with a strong preference for arachidonic
        acid (AA)... preferred various kinds of highly unsaturated fatty acids (HUFAs)
- term:
    id: GO:0005741
    label: mitochondrial outer membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-434382
  review:
    summary: Duplicate annotation (also IEA, IDA). Mitochondrial outer membrane localization
      is confirmed.
    action: ACCEPT
    reason: Multiple lines of evidence (TAS from Reactome, IEA from UniProt, IDA from
      PMID:38720107) support mitochondrial outer membrane localization.
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: &#39;SUBCELLULAR LOCATION: Mitochondrion outer membrane&#39;
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-548843
  review:
    summary: Duplicate annotation (also IEA). ER membrane localization is the primary
      site for ACSL4 function.
    action: ACCEPT
    reason: ER membrane localization is well-established as the primary site for ACSL4
      function. Multiple evidence types support this annotation.
    supported_by:
    - reference_id: PMID:24269233
      supporting_text: All 8 ACSs were localized either exclusively or partly to the
        endoplasmic reticulum (ER)
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: EXP
  original_reference_id: PMID:11889465
  review:
    summary: This landmark paper identified ACSL4/FACL4 mutations as the cause of
      X-linked intellectual disability and demonstrated reduced enzymatic activity
      in patient cells.
    action: ACCEPT
    reason: PMID:11889465 provides direct experimental evidence for ACSL4&#39;s long-chain
      fatty acid-CoA ligase activity through enzymatic assays of patient-derived cell
      lines. Mutations causing intellectual disability were shown to reduce enzymatic
      activity.
    supported_by:
    - reference_id: PMID:11889465
      supporting_text: Analysis of enzymatic activity in lymphoblastoid cell lines
        from affected individuals of both families revealed low levels compared with
        normal cells
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: EXP
  original_reference_id: PMID:12525535
  review:
    summary: Additional family with ACSL4 mutation showing reduced enzymatic activity,
      confirming the molecular function.
    action: ACCEPT
    reason: This paper reports a third MRX family with FACL4 mutation and proposes
      an enzymatic assay for screening, providing further experimental validation
      of ACSL4&#39;s ligase activity.
    supported_by:
    - reference_id: PMID:12525535
      supporting_text: proposal of a rapid enzymatic assay for screening mentally
        retarded patients
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:27842070
  review:
    summary: Landmark ferroptosis paper demonstrating ACSL4&#39;s enzymatic role in determining
      ferroptosis sensitivity through lipid composition.
    action: ACCEPT
    reason: PMID:27842070 used multiple approaches including CRISPR screens and biochemical
      assays to establish ACSL4&#39;s role in enriching membranes with long polyunsaturated
      fatty acids through its CoA ligase activity.
    supported_by:
    - reference_id: PMID:27842070
      supporting_text: &#34;Mechanistically, ACSL4 enriched cellular membranes with long\
        \ polyunsaturated \u03C96 fatty acids&#34;
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:31061331
  review:
    summary: Detailed biochemical characterization of recombinant human ACSL4 variants
      with substrate specificity analysis.
    action: ACCEPT
    reason: PMID:31061331 provides comprehensive enzymatic characterization using
      recombinant human ACSL4, demonstrating substrate preference for HUFAs including
      AA, DHA, and adrenic acid.
    supported_by:
    - reference_id: PMID:31061331
      supporting_text: both ACSL4 variants preferred various kinds of highly unsaturated
        fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic
        acid) and eicosapentaenoic acid (EPA), as well as AA as a substrate
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:35027735
  review:
    summary: Paper demonstrating PKCbetaII phosphorylation of ACSL4 amplifies lipid
      peroxidation to induce ferroptosis.
    action: ACCEPT
    reason: This study provides evidence for ACSL4 enzymatic activity in the context
      of ferroptosis induction via PKCbetaII-mediated phosphorylation.
    supported_by:
    - reference_id: PMID:35027735
      supporting_text: &#34;PKC\u03B2II senses the initial lipid peroxides and amplifies\
        \ lipid peroxidation linked to ferroptosis through phosphorylation and activation\
        \ of ACSL4&#34;
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:38720107
  review:
    summary: Study on tumor-repopulating cells evading ferroptosis via PCK2-dependent
      phospholipid remodeling, involving ACSL4.
    action: ACCEPT
    reason: This study provides additional evidence for ACSL4&#39;s enzymatic activity
      in the context of ferroptosis regulation in cancer cells.
    supported_by:
    - reference_id: PMID:38720107
      supporting_text: mitochondria metabolic kinase PCK2 phosphorylates and activates
        ACSL4 to drive ferroptosis-associated phospholipid remodeling
- term:
    id: GO:0005741
    label: mitochondrial outer membrane
  evidence_type: IDA
  original_reference_id: PMID:38720107
  review:
    summary: Direct evidence for ACSL4 localization to mitochondrial outer membrane.
    action: ACCEPT
    reason: IDA evidence from PMID:38720107 confirms ACSL4 localization to mitochondrial
      outer membrane, consistent with UniProt annotation and Reactome pathway data.
    supported_by:
    - reference_id: PMID:38720107
      supporting_text: mitochondria metabolic kinase PCK2 phosphorylates and activates
        ACSL4
- term:
    id: GO:0047676
    label: arachidonate-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:31061331
  review:
    summary: Detailed substrate specificity analysis confirms ACSL4&#39;s strong preference
      for arachidonic acid.
    action: ACCEPT
    reason: PMID:31061331 provides kinetic analysis demonstrating ACSL4&#39;s preference
      for arachidonic acid, confirming this as a core molecular function.
    supported_by:
    - reference_id: PMID:31061331
      supporting_text: ACSL4 is an ACSL isozyme with a strong preference for arachidonic
        acid (AA)
- term:
    id: GO:0160020
    label: positive regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:27842070
  review:
    summary: ACSL4 is established as a critical positive regulator of ferroptosis.
      This is a core biological function of ACSL4.
    action: ACCEPT
    reason: PMID:27842070 is the landmark paper establishing ACSL4 as essential for
      ferroptosis execution. ACSL4 knockout cells are resistant to ferroptosis, and
      ACSL4 expression predicts ferroptosis sensitivity in breast cancer cell lines.
    supported_by:
    - reference_id: PMID:27842070
      supporting_text: ACSL4 dictates ferroptosis sensitivity by shaping cellular
        lipid composition... Gpx4-Acsl4 double-knockout cells showed marked resistance
        to ferroptosis
- term:
    id: GO:0160020
    label: positive regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:35027735
  review:
    summary: PKCbetaII phosphorylates ACSL4 to amplify lipid peroxidation and ferroptosis.
    action: ACCEPT
    reason: This study provides mechanistic insight into how ACSL4 activity is regulated
      to promote ferroptosis, confirming its role as a positive regulator.
    supported_by:
    - reference_id: PMID:35027735
      supporting_text: &#34;PKC\u03B2II senses the initial lipid peroxides and amplifies\
        \ lipid peroxidation linked to ferroptosis through phosphorylation and activation\
        \ of ACSL4&#34;
- term:
    id: GO:0160020
    label: positive regulation of ferroptosis
  evidence_type: IDA
  original_reference_id: PMID:38720107
  review:
    summary: Additional evidence for ACSL4&#39;s role in ferroptosis from cancer cell
      studies.
    action: ACCEPT
    reason: Multiple independent studies confirm ACSL4 as a positive regulator of
      ferroptosis, making this a well-established core biological function.
    supported_by:
    - reference_id: PMID:38720107
      supporting_text: PCK2 phosphorylates and activates ACSL4 to drive ferroptosis-associated
        phospholipid remodeling
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  review:
    summary: High-throughput proteomics study identifying ACSL4 in the mitochondrial
      proteome.
    action: ACCEPT
    reason: HTP evidence from large-scale mitochondrial proteome study (PMID:34800366)
      confirms mitochondrial localization, consistent with the more specific GO:0005741
      annotation.
    supported_by:
    - reference_id: PMID:34800366
      supporting_text: defined a mitochondrial high-confidence proteome of &gt;1,100
        proteins (MitoCoP)
- term:
    id: GO:0001676
    label: long-chain fatty acid metabolic process
  evidence_type: IMP
  original_reference_id: PMID:22633490
  review:
    summary: Study establishing ACSL family members including ACSL4 in sphingosine
      1-phosphate metabolic pathway, involving long-chain fatty acid metabolism.
    action: ACCEPT
    reason: PMID:22633490 demonstrates ACSL family involvement in S1P degradation
      pathway, which involves long-chain fatty acid metabolism. ACSL4 activates hexadecenoic
      acid intermediates.
    supported_by:
    - reference_id: PMID:22633490
      supporting_text: yeast Faa1 and Faa4 and mammalian ACSL family members are acyl-CoA
        synthetases involved in the sphingolipid-to-glycerolipid metabolic pathway
- term:
    id: GO:0001676
    label: long-chain fatty acid metabolic process
  evidence_type: IDA
  original_reference_id: PMID:24269233
  review:
    summary: Study identifying acyl-CoA synthetases including ACSL4 in S1P metabolic
      pathway.
    action: ACCEPT
    reason: PMID:24269233 directly assayed ACSL4 activity in sphingosine 1-phosphate
      metabolism, confirming involvement in long-chain fatty acid metabolism.
    supported_by:
    - reference_id: PMID:24269233
      supporting_text: in addition to the previously identified ACSL family members
        (ACSL1, 3, 4, 5, and 6), we found that ACSVL1, ACSVL4, and ACSBG1 also restored
        metabolism
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IMP
  original_reference_id: PMID:22633490
  review:
    summary: Mutant phenotype studies demonstrating ACSL family function in S1P degradation.
    action: ACCEPT
    reason: IMP evidence from yeast mutant studies demonstrating role of ACSLs including
      ACSL4 in fatty acid activation pathway.
    supported_by:
    - reference_id: PMID:22633490
      supporting_text: &#34;hexadecenoic acid accumulates in \u0394faa1 \u0394faa4 mutant\
        \ cells&#34;
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:24269233
  review:
    summary: Direct assay of ACSL4 activity in heterologous expression system.
    action: ACCEPT
    reason: PMID:24269233 directly demonstrated ACSL4 enzymatic activity by restoring
      deficient sphingolipid-to-glycerolipid metabolism in yeast mutants.
    supported_by:
    - reference_id: PMID:24269233
      supporting_text: we cloned all 26 human ACS genes and examined their abilities
        to restore deficient sphingolipid-to-glycerophospholipid metabolism
- term:
    id: GO:0032024
    label: positive regulation of insulin secretion
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: Inferred from mouse ortholog (O35547) involvement in glucose-stimulated
      insulin secretion regulation.
    action: KEEP_AS_NON_CORE
    reason: This is a peripheral function inferred from mouse studies. ACSL4 modulates
      insulin secretion by regulating epoxyeicosatrienoic acid (EET) levels, but this
      is secondary to its core fatty acid-CoA ligase function. UniProt notes this
      function is &#34;By similarity&#34; from mouse.
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: stimulated insulin secretion by regulating the levels of unesterified
        EETs
- term:
    id: GO:0044233
    label: mitochondria-associated endoplasmic reticulum membrane contact site
  evidence_type: IDA
  original_reference_id: PMID:23455425
  review:
    summary: ACSL4 localizes to MAM (mitochondria-associated ER membrane) contact
      sites where autophagosomes form.
    action: ACCEPT
    reason: PMID:23455425 establishes that autophagosomes form at ER-mitochondria
      contact sites, and ACSL4 is found at these locations. This is consistent with
      ACSL4&#39;s presence at both ER and mitochondrial membranes.
    supported_by:
    - reference_id: PMID:23455425
      supporting_text: autophagosomes form at the ER-mitochondria contact site in
        mammalian cells
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  review:
    summary: High-throughput proteomics study identifying ACSL4 in membrane fractions.
      The term is very general.
    action: MARK_AS_OVER_ANNOTATED
    reason: &#39;&#39;&#39;Membrane&#39;&#39; is too general when more specific membrane localizations
      (ER membrane, mitochondrial outer membrane, plasma membrane) are established
      for ACSL4. HDA from proteomics appropriately reflects detection method but the
      term lacks specificity.&#39;
    proposed_replacement_terms:
    - id: GO:0005789
      label: endoplasmic reticulum membrane
    - id: GO:0005741
      label: mitochondrial outer membrane
    - id: GO:0005886
      label: plasma membrane
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19056867
  review:
    summary: ACSL4 detected in urinary exosome proteomics. This is likely a non-specific
      finding from high-throughput analysis.
    action: KEEP_AS_NON_CORE
    reason: Exosome localization is likely incidental contamination from ER/membrane
      proteins rather than a specific functional localization. ACSL4 is primarily
      an ER-resident enzyme. HDA evidence from urinary exosome proteomics does not
      indicate functional relevance to exosome biology.
    additional_reference_ids:
    - PMID:19056867
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:20458337
  review:
    summary: Second HDA annotation to extracellular exosome from B-cell exosome proteomics.
    action: KEEP_AS_NON_CORE
    reason: Same rationale as above - exosome detection is likely non-specific. Multiple
      HDA detections do not establish functional relevance. ACSL4 is not known to
      have exosome-specific functions.
    additional_reference_ids:
    - PMID:20458337
- term:
    id: GO:0005811
    label: lipid droplet
  evidence_type: IDA
  original_reference_id: PMID:14741744
  review:
    summary: ACSL4 identified in lipid droplet-enriched fraction from hepatocytes
      by mass spectrometry.
    action: ACCEPT
    reason: PMID:14741744 used careful subcellular fractionation and mass spectrometry
      to identify proteins in lipid droplet-enriched fractions. ACSL family members
      (ACS3 was abundant; ACSL4 related) were among the lipid-metabolizing enzymes
      identified. Lipid droplet localization is functionally relevant for fatty acid
      activation.
    supported_by:
    - reference_id: PMID:14741744
      supporting_text: 17 major proteins in the fraction were identified using nano
        LC-MS/MS techniques... Included in the identified proteins were five lipid-metabolizing
        enzymes
- term:
    id: GO:0031957
    label: very long-chain fatty acid-CoA ligase activity
  evidence_type: IMP
  original_reference_id: PMID:11889465
  review:
    summary: ACSL4 can activate very long-chain fatty acids, but this is not its preferred
      substrate class.
    action: KEEP_AS_NON_CORE
    reason: ACSL4 preferentially activates long-chain PUFAs (AA, AdA) rather than
      very long-chain fatty acids. The Reactome pathway R-HSA-75876 &#34;Synthesis of
      very long-chain fatty acyl-CoAs&#34; includes ACSL4, but this is secondary activity.
      ACSL4&#39;s primary substrates are C20-C22 PUFAs, which are at the border of long-chain
      and very long-chain.
    supported_by:
    - reference_id: PMID:31061331
      supporting_text: both ACSL4 variants preferred various kinds of highly unsaturated
        fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic
        acid)
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:11889465
  review:
    summary: ACSL4 is reported in cytoplasm, but it is primarily a membrane-associated
      protein.
    action: KEEP_AS_NON_CORE
    reason: ACSL4 is a type III membrane protein primarily localized to ER, mitochondrial
      outer membrane, and plasma membrane. Cytoplasmic localization may reflect soluble
      domains or processing intermediates rather than the primary functional localization.
    supported_by:
    - reference_id: UniProt:O60488
      supporting_text: Single-pass type III membrane protein
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IDA
  original_reference_id: PMID:9598324
  review:
    summary: Original cloning paper establishing ACSL4&#39;s role in lipid metabolism.
      The term is too general.
    action: MARK_AS_OVER_ANNOTATED
    reason: While technically correct, &#39;lipid metabolic process&#39; is too broad. The
      more specific GO:0001676 (long-chain fatty acid metabolic process) annotation
      already exists and better captures ACSL4&#39;s function. Consistent with IEA annotation
      for same term.
    proposed_replacement_terms:
    - id: GO:0001676
      label: long-chain fatty acid metabolic process
    supported_by:
    - reference_id: PMID:9598324
      supporting_text: plays an essential role in lipid biosynthesis and fatty acid
        degradation
- term:
    id: GO:0047676
    label: arachidonate-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:9598324
  review:
    summary: Original paper demonstrating ACSL4&#39;s preference for arachidonic acid.
    action: ACCEPT
    reason: PMID:9598324 is the original cloning paper that established ACSL4&#39;s substrate
      preference for arachidonic acid, making this a foundational annotation.
    supported_by:
    - reference_id: PMID:9598324
      supporting_text: The cDNA encodes a functional long-chain fatty acid-CoA ligase
        that shows preference for arachidonic acid as substrate
- term:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  evidence_type: IDA
  original_reference_id: PMID:10669417
  review:
    summary: The molecular function is correct for ACSL4, but the reference PMID:10669417
      (Roles of PLC-beta2 and -beta3...) appears incorrectly attributed. The function
      is well-established by other references.
    action: ACCEPT
    reason: Long-chain fatty acid-CoA ligase activity is the core molecular function
      of ACSL4, extensively validated by multiple other studies. The reference attribution
      may be erroneous but the functional annotation itself is correct. Keeping ACCEPT
      for consistency with other annotations to this term.
    supported_by:
    - reference_id: PMID:9598324
      supporting_text: The cDNA encodes a functional long-chain fatty acid-CoA ligase
        that shows preference for arachidonic acid as substrate
references:
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:9598324
  title: Cloning, expression, and chromosomal localization of human long-chain fatty
    acid-CoA ligase 4 (FACL4).
  findings:
  - statement: Original cloning of human ACSL4/FACL4 from brain library with substrate
      preference for arachidonic acid
    supporting_text: The cDNA encodes a functional long-chain fatty acid-CoA ligase
      that shows preference for arachidonic acid as substrate
- id: PMID:11889465
  title: FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked
    mental retardation.
  findings:
  - statement: FACL4/ACSL4 mutations cause X-linked intellectual disability with reduced
      enzymatic activity
    supporting_text: Analysis of enzymatic activity in lymphoblastoid cell lines from
      affected individuals of both families revealed low levels compared with normal
      cells
- id: PMID:12525535
  title: A third MRX family (MRX68) is the result of mutation in the long chain fatty
    acid-CoA ligase 4 (FACL4) gene
  findings:
  - statement: Third family with FACL4/ACSL4 mutation causing mental retardation
    supporting_text: proposal of a rapid enzymatic assay for screening mentally retarded
      patients
- id: PMID:14741744
  title: Identification of major proteins in the lipid droplet-enriched fraction isolated
    from the human hepatocyte cell line HuH7.
  findings:
  - statement: ACSL family members identified in lipid droplet-enriched fraction by
      mass spectrometry
    supporting_text: 17 major proteins in the fraction were identified using nano
      LC-MS/MS techniques... Included in the identified proteins were five lipid-metabolizing
      enzymes
- id: PMID:21242590
  title: &#34;Long-chain acyl-CoA synthetase 4 modulates prostaglandin E\u2082 release\
    \ from human arterial smooth muscle cells.&#34;
  findings:
  - statement: ACSL4 preferentially activates arachidonate and eicosapentaenoate with
      EC 6.2.1.3 and EC 6.2.1.15 activities
    supporting_text: Purified ACSL4 is an arachidonic acid (20:4)-preferring ACSL
      isoform
- id: PMID:22633490
  title: &#34;The Sj\xF6gren-Larsson syndrome gene encodes a hexadecenal dehydrogenase\
    \ of the sphingosine 1-phosphate degradation pathway.&#34;
  findings:
  - statement: ACSL family members involved in sphingolipid-to-glycerolipid metabolic
      pathway
    supporting_text: yeast Faa1 and Faa4 and mammalian ACSL family members are acyl-CoA
      synthetases involved in the sphingolipid-to-glycerolipid metabolic pathway
- id: PMID:23455425
  title: Autophagosomes form at ER-mitochondria contact sites.
  findings:
  - statement: Autophagosomes form at ER-mitochondria contact sites (MAM)
    supporting_text: autophagosomes form at the ER-mitochondria contact site in mammalian
      cells
- id: PMID:24269233
  title: Identification of acyl-CoA synthetases involved in the mammalian sphingosine
    1-phosphate metabolic pathway.
  findings:
  - statement: All active ACSs including ACSL4 localized to ER where S1P metabolism
      occurs
    supporting_text: All 8 ACSs were localized either exclusively or partly to the
      endoplasmic reticulum (ER), where S1P metabolism takes place
- id: PMID:27842070
  title: ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
  findings:
  - statement: Landmark paper establishing ACSL4 as essential for ferroptosis execution
    supporting_text: ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid
      composition... Gpx4-Acsl4 double-knockout cells showed marked resistance to
      ferroptosis
- id: PMID:31061331
  title: Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase
    ACSL4 Variants.
  findings:
  - statement: Both ACSL4 variants prefer HUFAs including DHA, adrenic acid, EPA,
      and AA
    supporting_text: both ACSL4 variants preferred various kinds of highly unsaturated
      fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic
      acid) and eicosapentaenoic acid (EPA), as well as AA as a substrate
- id: PMID:35027735
  title: &#34;PKC\u03B2II phosphorylates ACSL4 to amplify lipid peroxidation to induce\
    \ ferroptosis.&#34;
  findings: []
- id: PMID:38720107
  title: Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid
    remodeling.
  findings: []
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings: []
- id: PMID:19056867
  title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
  findings: []
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
- id: PMID:20458337
  title: MHC class II-associated proteins in B-cell exosomes and potential functional
    implications for exosome biogenesis.
  findings: []
- id: Reactome:R-HSA-434313
  title: Intracellular metabolism of fatty acids regulates insulin secretion
  findings: []
- id: Reactome:R-HSA-434382
  title: ACSL3,4 ligates coenzyme A (CoA-SH) to a long chain fatty acid yielding fatty
    acyl-coenzyme A
  findings: []
- id: Reactome:R-HSA-548843
  title: ACSL3,4 ligate CoA to AA to form AA-CoA
  findings: []
- id: Reactome:R-HSA-75876
  title: Synthesis of very long-chain fatty acyl-CoAs
  findings: []
- id: PMID:10669417
  title: Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal
    transduction.
  findings: []
core_functions:
- description: Primary enzymatic function (EC 6.2.1.3). Extensively validated by multiple
    experimental studies including direct enzymatic assays, patient mutation studies,
    and recombinant protein characterization.
  molecular_function:
    id: GO:0004467
    label: long-chain fatty acid-CoA ligase activity
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  directly_involved_in:
  - id: GO:0035338
    label: long-chain fatty-acyl-CoA biosynthetic process
- description: Specific activity for arachidonic acid (EC 6.2.1.15). ACSL4 shows marked
    preference for arachidonic acid and adrenic acid over other fatty acids. Core
    substrate specificity.
  molecular_function:
    id: GO:0047676
    label: arachidonate-CoA ligase activity
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  directly_involved_in:
  - id: GO:0160020
    label: positive regulation of ferroptosis
proposed_new_terms: []
suggested_questions:
- question: What are the relative contributions of ACSL4 versus other ACSL family
    members to ferroptosis in different tissue contexts?
- question: Does ACSL4&#39;s role in neuronal function relate primarily to ferroptosis
    or to other lipid-dependent processes?
suggested_experiments:
- description: Lipidomic analysis comparing AA-CoA and AdA-CoA levels in ACSL4 knockout
    versus wild-type cells across different tissue types. This would quantify the
    specific contribution of ACSL4 to PUFA-CoA pools in different cellular contexts.
  hypothesis: ACSL4 is the primary source of AA-CoA and AdA-CoA in ferroptosis-sensitive
    tissues
- description: Structure-function analysis of ACSL4 disease-causing mutations to understand
    substrate specificity determinants. This would inform both disease mechanisms
    and potential therapeutic interventions.
  hypothesis: Disease mutations affect substrate binding or catalytic efficiency
tags:
- ferroptosis
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>